Electrosurgical system

Description

BACKGROUND

The present application relates generally to electrosurgical systems and methods and more particularly relates to electrosurgical generators and advanced bipolar electrosurgical devices or instruments.

Electrosurgical devices or instruments have become available that use electrical energy to perform certain surgical tasks. Typically, electrosurgical instruments are hand tools such as graspers, scissors, tweezers, blades, needles, and other hand tools that include one or more electrodes that are configured to be supplied with electrical energy from an electrosurgical generator including a power supply. The electrical energy can be used to coagulate, fuse, or cut tissue to which it is applied.

Electrosurgical instruments typically fall within two classifications: monopolar and bipolar. In monopolar instruments, electrical energy is supplied to one or more electrodes on the instrument with high current density while a separate return electrode is electrically coupled to a patient and is often designed to minimize current density. Monopolar electrosurgical instruments can be useful in certain procedures, but can include a risk of certain types of patient injuries such as electrical burns often at least partially attributable to functioning of the return electrode. In bipolar electrosurgical instruments, one or more electrodes is electrically coupled to a source of electrical energy of a first polarity and one or more other electrodes is electrically coupled to a source of electrical energy of a second polarity opposite the first polarity. Thus, bipolar electrosurgical instruments, which operate without separate return electrodes, can deliver electrical signals to a focused tissue area with reduced risks.

Even with the relatively focused surgical effects of bipolar electrosurgical instruments, however, surgical outcomes are often highly dependent on surgeon skill. For example, thermal tissue damage and necrosis can occur in instances where electrical energy is delivered for a relatively long duration or where a relatively high-powered electrical signal is delivered even for a short duration. The rate at which a tissue will achieve the desired coagulation or cutting effect upon the application of electrical energy varies based on the tissue type and can also vary based on pressure applied to the tissue by an electrosurgical instrument. However, even for a highly experienced surgeon, it can be difficult for a surgeon to assess how quickly a mass of combined tissue types grasped in an electrosurgical instrument will be fused a desirable amount.

Attempts have been made to reduce the risk of tissue damage during electrosurgical procedures. For example, previous electrosurgical systems have included generators that monitor an ohmic resistance or tissue temperature during the electrosurgical procedure, and terminated electrical energy once a predetermined point was reached. However, these systems have had shortcomings in that they can provide inconsistent results at determining tissue coagulation, fusion, or cutting endpoints for varied tissue types or combined tissue masses. These systems can also fail to provide consistent electrosurgical results among use of different instruments having different instrument and electrode geometries. Typically, even where the change is a relatively minor upgrade to instrument geometry during a product's lifespan, the electrosurgical generator must be recalibrated for each instrument type to be used, a costly, time consuming procedure which can undesirably remove an electrosurgical generator from service.

SUMMARY

In certain embodiments, an electrosurgical system for performing electrosurgical procedures on body tissue of a patient comprises an electrosurgical generator and a bipolar electrosurgical device or instrument. The generator controls the delivery of electrosurgical energy to fuse tissue in contact with the bipolar electrosurgical device. The generator in various embodiments identifies a phase zero crossing, adjusts the RF energy output or voltage and measures and monitors a phase angle and/or a change of phase angle rate relative to a predetermined threshold with the predetermined threshold identified at the identified phase zero crossing.

In accordance with various embodiments, an electrosurgical fusion device comprises first jaw coupled to a second jaw with the first jaw having a first electrode and the second jaw having a second electrode facing the first electrode. The first and second electrodes are arranged to conduct radio frequency (RF) energy between the first and second electrodes and the first and second electrodes are made of the same conductive material. The electrosurgical fusion device also includes an elongate shaft having a proximal end and a distal end and a longitudinal axis extending from the proximal end to the distal end, the first and second jaws being pivotably coupled to the distal end of the elongate shaft. The elongate shaft in one embodiment has an outer diameter of less than 5 mm to fit through a 5 mm cannula.

In accordance with various embodiments, the electrosurgical fusion device comprises a conductive post incorporated into the second jaw and extending from the second jaw towards the first jaw. The conductive post is stationary and is made of the same conductive material as the first and second electrodes. In various embodiments, the conductive post includes a plurality of conductive posts having varying heights.

In accordance with various embodiments, the electrosurgical fusion device comprises a first jaw having a conductive pad with a second jaw coupled to the first jaw. The second jaw having an inner surface facing the conductive pad with the first and second jaws arranged to capture tissue between the conductive pad and the inner surface of the second jaw. The conductive pad and the second jaw are arranged to connect to an electrosurgical energy source and arranged to conduct RF energy through tissue held between the jaws. The electrosurgical fusion device also comprises a blade movable along a longitudinal axis from a proximal position to a distal position and back to the proximal position with the blade disposed within an outer periphery of the second jaw.

In accordance with various embodiments, the electro surgical fusion device comprises a conductive post disposed on the second jaw and adjacent to the blade. The conductive post is arranged to not connect to the electrosurgical energy source and is arranged to conduct RF energy between the conductive pad or the second jaw through the tissue held between the jaws.

Many of the attendant features of the present inventions will be more readily appreciated as the same becomes better understood by reference to the foregoing and following description and considered in connection with the accompanying drawings.

BRIEF DESCRIPTION OF THE DRAWINGS

The present inventions may be better understood taken in connection with the accompanying drawings in which the reference numerals designate like parts throughout the figures thereof.

FIG. 1 is a perspective view of an electrosurgical system in accordance with various embodiments of the present invention.

FIG. 2 is a perspective view of an electrosurgical generator in accordance with various embodiments of the present invention.

FIG. 3 is a flow chart illustrating operations of an electrosurgical system in accordance with various embodiments of the present invention.

FIGS. 4-1 to 4-2 are schematic block diagrams of an embodiment of electrosurgical system.

FIGS. 5 to 6 are schematic block diagrams of portions of an electrosurgical system in accordance with various embodiments of the present invention.

FIG. 6-1 is a schematic block diagram of portions of an electrosurgical system in accordance with various embodiments of the present invention.

FIG. 6-2 is a signal diagram illustrating operations of an electrosurgical system in accordance with various embodiments of the present invention.

FIG. 6-3 is a schematic block diagram of portions of an electrosurgical system in accordance with various embodiments of the present invention.

FIGS. 6-4 to 6-12 are signal diagrams illustrating operations of an electrosurgical system in accordance with various embodiments of the present invention.

FIGS. 7 to 9 are schematic block diagrams of portions of an electrosurgical system in accordance with various embodiments of the present invention.

FIG. 10 is a flow chart illustrating operations of an electrosurgical system in accordance with various embodiments of the present invention.

FIGS. 11A-11B are flow charts illustrating operations of an electrosurgical system in accordance with various embodiments of the present invention.

FIGS. 12-20 are graphical representations of exemplary data or results provided by an electrosurgical system in accordance with various embodiments of the present invention.

FIG. 21 is a perspective view of an electrosurgical fusion device in accordance with various embodiments of the present invention.

FIG. 22 is a perspective view of a portion of an electrosurgical fusion device in accordance with various embodiments of the present invention.

FIG. 23 is a perspective view of a distal end of the electrosurgical device in accordance with various embodiments of the present invention.

FIG. 24 is a perspective view of a distal end of an electrosurgical device in accordance with various embodiments of the present invention.

FIG. 25 is a side cross-sectional view of a distal end of an electrosurgical device in accordance with various embodiments of the present invention.

FIG. 26 is a side view of a distal end of an electrosurgical device in accordance with various embodiments of the present invention.

FIG. 27 is a side cross-sectional view of an electrosurgical device in accordance with various embodiments of the present invention.

FIG. 28 is a side view of a distal end of an electrosurgical device in accordance with various embodiments of the present invention.

FIG. 29 is a side cross-sectional view of a distal end of an electrosurgical device in accordance with various embodiments of the present invention.

FIG. 30 is a side cross-sectional view of an electrosurgical device in accordance with various embodiments of the present invention.

FIG. 31 is a side cross-sectional view of a portion of an actuator of an electrosurgical device in accordance with various embodiments of the present invention.

FIG. 32 is a side cross-sectional view of an electrosurgical device in accordance with various embodiments of the present invention.

FIG. 33 is a side cross-sectional view of a portion of an actuator of an electrosurgical device in accordance with various embodiments of the present invention.

FIG. 34 is a side cross-sectional view of a distal end of an electrosurgical device in accordance with various embodiments of the present invention.

FIG. 35 is a front cross-sectional view of a distal end of an electrosurgical device in accordance with various embodiments of the present invention.

FIG. 36 is a perspective view of a post in accordance with various embodiments of the present invention.

FIG. 37 is a side view of a post in accordance with various embodiments of the present invention.

FIG. 38 is a front cross-sectional view of a distal end of an electrosurgical device in accordance with various embodiments of the present invention.

FIG. 39 is a front cross-sectional view of a distal end of an electrosurgical device in accordance with various embodiments of the present invention.

FIG. 40 is a front cross-sectional view of a distal end of an electrosurgical device in accordance with various embodiments of the present invention.

DETAILED DESCRIPTION

In accordance with various embodiments, an electrosurgical system is provided that includes an electrosurgical generator and an electrosurgical instrument that are configured to optimally fuse tissue. The electrosurgical instrument in accordance with various embodiments is provided to be used in laparoscopic surgery with the ability to move, grasp and compress tissue and to deliver RF energy to fuse the tissue. In accordance with various embodiments, the electrosurgical instrument is a bipolar electrosurgical instrument insertable through a 5 mm trocar and cuts tissue through actuation of a mechanical cutting blade. The RF energy is supplied by the electrosurgical generator configured to provide the appropriate RF energy to fuse the tissue. The generator in accordance with various embodiments determines the appropriate RF energy and the appropriate manner to deliver the RF energy for the particular connected electrosurgical instrument, the particular tissue in contact with the instrument and/or a particular surgical procedure. In accordance with various embodiments, information or data to assist in the determination of the appropriate RF energy and manner to deliver the RF energy is supplied or obtained externally from the generator. The external source in various embodiments is one or more memory modules that may be included with the electrosurgical instrument or via connections therebetween (wired or wireless) or via a separate tool, accessory and/or adapter and/or connections therebetween and/or via a separate port or connection to the generator. The generator retrieves and/or receives the data and utilizes the data to command or operate the generator to determine and supply the appropriate RF energy in the appropriate manner.

Generally, in accordance with various embodiments, a bipolar electrosurgical fusion instrument or tool is provided that is arranged to fuse tissue captured between jaws. The jaws extend from an elongate shaft coupled to an actuator. The actuator is user accessible by which a user can manipulate the jaws to open and close the jaws and change their orientation or position. A user through the actuator can also initiate fusion of issue in contact with the jaws. The jaws in various embodiments includes an electrode on each jaw that are capable of being connected to an electrosurgical energy source, such as an electrosurgical generator, to conduct radio frequency (RF) energy therebetween and the tissue captured between the jaws. A movable blade is also provided to cut tissue captured between the jaws. In accordance with various embodiments, at least one jaw includes at least one conductive post that is positioned between the blade and an electrode of that jaw. The conductive post is made of the same conductive material as the electrodes of the jaws, but unlike the electrodes is not connected or capable of being connected to an electrosurgical generator to conduct RF energy therebetween. The conductive post however in accordance with various embodiments may participate in conducting electrosurgical energy between the jaws and the tissue therebetween.

Referring to FIGS. 1-2, an exemplary embodiment of electrosurgical system is illustrated including an electrosurgical generator 10 and a removably connectable electrosurgical instrument 20. The electrosurgical instrument 20 can be electrically coupled to the generator via a cabled connection 30 to a tool or device port 12 on the generator. The electrosurgical instrument 20 may include audio, tactile and/or visual indicators to apprise a user of a particular predetermined status of the instrument such as a start and/or end of a fusion or cut operation. In other embodiments, the electrosurgical instrument 20 can be reusable and/or connectable to another electrosurgical generator for another surgical procedure. In some embodiments, a manual controller such as a hand or foot switch can be connectable to the generator and/or instrument to allow predetermined selective control of the instrument such as to commence a fusion or cut operation.

In accordance with various embodiments, the electrosurgical generator 10 is configured to generate radiofrequency (RF) electrosurgical energy and to receive data or information from the electrosurgical instrument 20 electrically coupled to the generator. The generator 10 in one embodiment outputs RF energy (375 VA, 150V, 5 A at 350 kHz) and in one embodiment is configured to calculate a phase angle or difference between RF output voltage and RF output current during activation or supply of RF energy. The generator regulates voltage, current and/or power and monitors RF energy output (e.g., voltage, current, power and/or phase). In one embodiment, the generator 10 stops RF energy output under predefine conditions such as when a device switch is de-asserted (e.g., fuse button released), a time value is met, and/or active phase angle and/or change of phase is greater than or equal to a phase and/or change of phase stop value.

The electrosurgical generator 10 comprises two advanced bipolar tool ports 12, a standard bipolar tool port 16, and an electrical power port 14. In other embodiments, electrosurgical units can comprise different numbers of ports. For example, in some embodiments, an electrosurgical generator can comprise more or fewer than two advanced bipolar tool ports, more or fewer than the standard bipolar tool port, and more or fewer than the power port. In one embodiment, the electrosurgical generator comprises only two advanced bipolar tool ports.

In accordance with various embodiments, each advanced bipolar tool port 12 is configured to be coupled to electrosurgical instrument having an attached or integrated memory module. The standard bipolar tool port 16 is configured to receive a non-specialized bipolar electrosurgical tool that differs from the advanced bipolar electrosurgical instrument connectable to the advanced bipolar tool port 12. The electrical power port 14 is configured to receive or be connected to a direct current (DC) accessory device that differs from the non-specialized bipolar electrosurgical tool and the advanced electrosurgical instrument. The electrical power port 14 is configured to supply direct current voltage. For example, in some embodiments, the power port 14 can provide approximately 12 Volts DC. The power port 14 can be configured to power a surgical accessory, such as a respirator, pump, light, or another surgical accessory. Thus, in addition to replacing electrosurgical generator for standard or non-specialized bipolar tools, the electrosurgical generator can also replace a surgical accessory power supply. In some embodiments, replacing presently-existing generators and power supplies with the electrosurgical generator can reduce the amount of storage space required on storage racks cards or shelves in the number of mains power cords required in a surgical workspace.

In one embodiment, connection of a non-specialized bipolar tool into the standard bipolar port will not cause the generator to actively check the tool. However, the generator recognizes a connection so that the information of the non-specialized bipolar tool can be displayed. In accordance with various embodiments, the generator recognizes device connection status for each of the advanced tool ports 12 and authenticates connected devices before accepting RF energy activation requests (e.g., activation of an instrument switch such as a fuse button). The generator in one embodiment reads authenticated data from the connected device and reads electrical control values (such as but not limited to voltage level settings, current level settings, power level settings, active phase angle level settings, RF energy output activation timing limits, instrument short limits, instrument open limits, instrument model/identification, RF energy output line configurations, switch state command configurations and/or combinations thereof) from the authenticated and connected device.

In accordance with various embodiments, the electrosurgical generator 10 can comprise a display 15. The display can be configured to indicate the status of the electrosurgical system including, among other information, the status of the one or more electrosurgical instruments and/or accessories, connectors or connections thereto. In some embodiments, the display can comprise a multi-line display capable of presenting text and graphical information such as for example an LCD panel display, which, in some embodiments can be illuminated via backlight or sidelight. In some embodiments, the display can comprise a multi-color display that can be configured to display information about a particular instrument electrically coupled to the electrosurgical generator and a color that corresponds to a particular surgical procedure (such as, for example cutting operations displayed in yellow text and graphics, fusion or welding operations displayed in purple, and coagulation displayed in blue, bloodless dissection operations can be displayed in yellow and blue).

In some embodiments, the display can be configured to simultaneously indicate status data for a plurality of instruments electrically coupled to the electrosurgical generator and/or be portioned to display status information for each instrument connected to a corresponding tool port. A visual indicator such as a status bar graph can be used to illustrate a proportion of total available electrical energy to be applied to the bipolar electrosurgical instrument when actuated. In various embodiments, an electrosurgical instrument operable to cut, coagulate, or fuse tissue could have three color-coded displays or bar graphs. In some embodiments, a user can toggle the display between presenting status of multiple electrically connected instruments and status of a single electrically connected instrument. In accordance with various embodiments, once an instrument and/or accessory is connected and/or detected a window opens in the user interface display showing the type of instrument connected and status.

The electrosurgical generator in accordance with various embodiments can comprise a user interface such as, for example a plurality of buttons 17. The buttons can allow user interaction with the electrosurgical generator such as, for example, requesting an increase or decrease in the electrical energy supplied to one or more instruments coupled to the electrosurgical generator. In other embodiments, the display 15 can be a touch screen display thus integrating data display and user interface functionalities. In accordance with various embodiments, through the user interface, the surgeon can set a voltage setting by the selection of one to three levels. For example, at level 1, voltage is set to 110V; at level 2, voltage is set to 100V; and at level 3, voltage is set to 90V. Current is set to 5 Amps and power is set to 300 VA for all three levels. In other embodiments, the voltage is preset or defaults to a specific level such as level 2. In other embodiments, like the current and power settings, the voltage setting is not user adjustable to simplify operation of the generator and as such a predetermined default voltage setting is utilized, e.g., voltage is set to 100V.

In one embodiment, the electrosurgical tool or instrument 20 can further comprise of one or more memory modules. In some embodiments, the memory comprises operational data concerning the instrument and/or other instruments. For example, in some embodiments, the operational data may include information regarding electrode configuration/reconfiguration, the instrument uses, operational time, voltage, power, phase and/or current settings, and/or particular operational states, conditions, scripts, processes or procedures. In one embodiment, the generator initiate reads and/or writes to the memory module.

In one embodiment, each advanced bipolar electrosurgical instrument comes with a memory module and/or an integrated circuit that provides instrument authentication, configuration, expiration, and logging. Connection of such instruments into the receptacles or ports initiates an instrument verification and identification process. Instrument authentication in one embodiment is provided via a challenge-response scheme and/or a stored secret key also shared by the generator. Other parameters have hash keys for integrity checks. Usages are logged to the generator and/or to the instrument integrated circuit and/or memory. Errors in one embodiment can result in unlogged usage. In one embodiment, the log record is set in binary and interpreted with offline instruments or via the generator.

In one embodiment, the generator uses time measurement components to monitor a instrument's expiration. Such components utilize polling oscillators or timers or real-time calendar clocks that are configured at boot time. Timer interrupts are handled by the generator and can be used by scripts for timeout events. Logging also utilizes timers or counters to timestamp logged events.

In accordance with various embodiments, the generator provides the capability to read the phase difference between the voltage and current of the RF energy sent to the connected electrosurgical instrument while RF energy is active. While tissue is being fused, phase readings are used to detect different states during the fuse process.

In one embodiment, the generator logs usage details in an internal log that is down loadable. The generator has memory for storage of code and machine performance. The generator has reprogrammable memory that contains instructions for specific instrument performance. The memory for example retains a serial number and instrument use parameters. The generator stores information on the type of instruments connected. Such information includes but is not limited to an instrument identifier, e.g., a serial number of a connected instrument, along with a time stamp, number of uses or duration of use of the connected instrument, power setting of each and changes made to the default setting. The memory in one embodiment holds data for about two months, about 10,000 instrument uses or up to 150 logged activations and is configured to overwrite itself as needed.

The generator in accordance with various embodiments does not monitor or control current, power or impedance. The generator regulates voltage and can adjust voltage. Electrosurgical power delivered is a function of applied voltage, current and tissue impedance. The generator through the regulation of voltage can affect the electrosurgical power being delivered. However, by increasing or decreasing voltage, delivered electrosurgical power does not necessarily increase or decrease. Power reactions are caused by the power interacting with the tissue or the state of the tissue without any control by a generator other than by the generator supplying power.

The generator once it starts to deliver electrosurgical power does so continuously, e.g., every 150 ms, until a fault occurs or a specific phase parameter is reached. In one example, the jaws of the electrosurgical instrument can be opened and thus compression relieved at any time before, during and after the application of electrosurgical power. The generator in one embodiment also does not pause or wait a particular duration or a predetermined time delay to commence termination of the electrosurgical energy.

In one embodiment, an electrosurgical process such as a tissue fusion process starts with depressing a switch on the instrument or tool (51), which starts an initial measurement sequence as illustrated in FIG. 3. With engagement of a switch on the tool, the generator takes initial measurements on the tissue (opens, shorts, etc.) (52) and based on the initial measurements initiates or does not initiate the supply of RF energy (53). In accordance with various embodiments, the generator measures tool and/or tissue impedance and/or resistance, and/or if a phase angle is within an acceptable range. In one embodiment, the generator performs a measurement of tissue between the electrodes of an electrosurgical instrument connected to the generator utilizing RF energy with a low energy range (e.g., a voltage about 1-10 Volts) that does not cause a physiological effect (i.e., a passive measurement). In various embodiments, the generator uses the initial impedance measurement to determine if the instrument is shorted, faulty, open and the like. Based on a positive result of the initial check, the generator switches—in a supply of RF energy from the generator to the electrosurgical instrument and ultimately to the tissue (54). After RF power is turned on and is being supplied continuously by the generator, the generator monitors the phase angle or difference and/or change of phase angle between current and voltage of the supplied RF energy (55).

At or upon a predefined point, condition or threshold (56), the supply of RF energy is terminated (57). In this case, an acoustical and/or visual signal is provided indicating that the tissue is fused (or that an error has occurred (e.g., shorting of the electrodes) and/or an unexpected condition has occurred (e.g., permissible although unexpected switch release)). In accordance with various embodiments, the predefined point, condition or threshold and/or initialization checks are determined based on an instrument algorithm or script provided for a connected electrosurgical instrument, procedure or preference. In accordance with various embodiments, the product of measured tissue permittivity and conductivity or an initial phase shift is utilized to determine the end point for a connected instrument.

Referring now to FIG. 4-1, in one embodiment, the electrosurgical generator 10 is connected to AC main input and a power supply 41 converts the AC voltage from the AC main input to DC voltages for powering various circuitry of the generator. The power supply also supplies DC voltage to an RF amplifier 42 that generates RF energy. In one embodiment, the RF amplifier 42 converts 100 VDC from the power supply to a sinusoidal waveform with a frequency of 350 kHz which is delivered through a connected electrosurgical instrument. RF sense circuitry 43 measures/calculates voltage, current, power and phase at the output of the generator in which RF energy is supplied to a connected electrosurgical instrument 20. The measured/calculated information is supplied to a controller 44.

In one embodiment, the RF sense analyzes the measured AC voltage and current from the RF amplifier and generates DC signals for control signals including voltage, current, power, and phase that are sent to the controller for further processing. In one embodiment, RF sense circuitry 43 measures the output voltage and current and calculates the root means square (RMS) of the voltage and current, apparent power of the RF output energy and the phase angle between the voltage and current of the RF energy being supplied through a connected electrosurgical instrument. In particular, the voltage and current of the output RF energy are processed by analog circuitry of the RF sense to generate real and imaginary components of both voltage and current. These signals are processed by an FPGA to give different measurements relating to voltage and current, including the RMS measurements of the AC signals, phase shift between voltage and current, and power. Accordingly, in one embodiment, the output voltage and current are measured in analog, converted to digital, processed by an FPGA to calculate RMS voltage and current, apparent power and phase angle between voltage and current, and then are converted back to analog for the controller.

Referring now also to FIG. 4-2, for each device port 45a, 45b there are a pair of signals for voltage and a pair of signals for current that originate from the RF amplifier 42. In one embodiment, the generator has two redundant RF sense circuits 43a, 43b that measures voltage and current for each device at different locations on the RF amplifier. The first RF Sense circuit senses current 145a, 145b by sense resistor 141, 142, delivered through a connected electrosurgical instrument on either device port 1 or device port 2, and the voltage 148a, 148b measured across return to output on either device port 1 or device port 2. The second RF Sense circuit senses current 147a, 147b by sense resistor 143, 144, returned from a connected electrosurgical instrument on either device port 1 or device port 2, and the voltage 146a, 146b measured across output to return on either device port 1 or device port 2. The voltage input signals are high voltage sinusoidal waveforms at 350 kHz that are attenuated and AC coupled by a voltage divider and an inverting filter to remove DC bias on the signals. An inverting filter is used as the voltage and current inputs are 180 degrees out of phase as they are measured at opposite polarities. For each voltage input signal, two separate inverted and non-inverted voltage sense signals are generated. In one embodiment, a differential voltage measurement is made between the current input signals to generate two separate pairs of inverted and non-inverted current sense signals. The current input signals represent voltage across a shunt resistor on the RF Amplifier in which this voltage is proportional to the current flowing through the shunt resistor. The current input signals are low voltage sinusoidal waveforms at 350 kHz that are amplified using a non-inverting filter to remove DC bias on the signals. The RF Sense generates a signal that is analogous to multiplying each voltage and current signal by predetermined reference signals. As such, the RF Sense provides the non-inverted voltage and current sense signals when the waveform is positive, the inverted voltage and current sense signals when the waveform is negative, and a ground signal when the waveform is zero.

The RF sense in accordance with various embodiments receives four reference synchronization signals supplied by the controller via the RF amplifier. The synchronization signals are 350 kHz pulse signals with the same duty cycle but with differing phase shifts and in one embodiment are 90 degrees phase shifted from each other. Two of the synchronization signals are used to generate the in-phase waveforms to generate the real component of the input waveforms and the two other synchronization signals are used to generate the quadrature waveforms to generate the imaginary components of the input waveforms. These signals are processed further to generate control signals to a plurality of switches. The outputs of the switches are tied together to generate a single output. In one embodiment, the control signals to the switches determine which input signal passes through to the single output. In accordance with various embodiments, a first combination allows non-inverted voltage and current sense signals to pass through which represents or is analogous to multiplying these sense signals by a positive pulse. A second combination allows the inverted voltage and current sense signals to pass through which represents or is analogous to multiplying these sense signals by a negative pulse. A third combination allows the ground signal to pass through generating a zero voltage output which represents or is analogous to multiplying the sense signals by zero. Each output is supplied to a low pass filter that generates a DC voltage corresponding to the real or imaginary component of the sensed signals. These signals supplied to ADCs which sends a digital signal to the FPGA.

In one embodiment, Controller 44 controls the RF amplifier 42 to affect the output RF energy. For example, Controller utilizes the information provided by the RF sense 3 to determine if RF energy should be outputted and when to terminate the output of RF energy. In one embodiment, the controller compares a predetermined phase threshold based on a particular tissue in contact with the connected electrosurgical device 20 to determine when to terminate the output of RF energy. In various embodiments, the controller performs a fusion process described in greater detail below and in some embodiments the controller receives the instructions and settings or script data to perform the fusion process from data transmitted from the electrosurgical instrument.

In accordance with various embodiments as shown in FIG. 4-2, the generator has six major sub-systems or modules of circuitry that include System Power or Power Supply 45, Controller 44, Front Panel Interface 46, Advanced Bipolar Device Interface 47, RF Amplifier 42 and RF Sense 43. In accordance with various embodiments, one or more of the circuitry may be combined or incorporated with other circuitry. The Power supply 45 is configured to provide DC voltages to all the other circuitry or sub-systems along with control signals to control the power supply outputs. The power supply receives AC power input that is 90-264 VAC, 47-63 Hz and in one embodiment the power supply has a switch, integrated or separate, that is configured to connect or disconnect the AC power input from the generator. The controller through the Front Panel Interface (FPI) and Advanced Bipolar Device Interface (ABDI) supports the user interface 21 and instrument connections for electrosurgical devices 1 and 2 connected to the electrosurgical generator.

The RF Amplifier 42 generates high power RF energy to be passed through a connected electrosurgical instrument and in one example, an electrosurgical instrument for fusing of tissue. The RF Amplifier in accordance with various embodiments is configured to convert a 100 VDC power source to a high power sinusoidal waveform with a frequency of 350 kHz which is delivered through the ABDI 47 and eventually the connected electrosurgical device. The RF Sense 43 interprets the measured AC voltage and current from the RF amplifier 42 and generates DC control signals, including voltage, current, power, and phase, that is interpreted by Controller 44.

The generator has a plurality of specialized connection receptacles, in the illustrated embodiment device port 1 and device port 2, that are used only for connecting to advanced bipolar devices, such as the electrosurgical fusion instrument described in greater detail below. The specialized receptacles each include an array spring-loaded probes or pogo pins. The generator in various embodiments includes a circuit to detect the presence of an advanced bipolar device prior to energizing any active output terminals at the receptacles.

The Front Panel Interface (FPI) 46 is configured to drive a display, device signals from the controllers and LED backlights for front panel buttons. The FPI is also configured to provide power isolation through regulators and provide functionality for the front panel switches/buttons. In one embodiment, the ABDI 47 is used as a pass-through connection which provides a connection to the devices through the FPI. The FPI also provides connection between Controller 44 and a connected electrosurgical device through the ABDI. The device interface in one embodiment is electrically isolated from the rest of the FPI. The interface in various embodiments includes lines that read and write to an FRAM on an advanced bipolar device, read a trigger switch and/or read a signal that indicates a device is connected. In one embodiment, a device memory circuit is provided that utilizes the controller's SPI interface to read and write the FRAM of the advanced bipolar device. In one embodiment, the FRAM is replaced with a microcontroller and the interface includes an interrupt line so all information passed through a digital interface between the electrosurgical device and the generator. FPI provides isolation for SPI signals to and from advanced bipolar device through ABDI. In one embodiment, the SPI interface is shared between two advanced bipolar devices with port pins being used as chip selects.

In accordance with various embodiments, the generator includes a SPI communication bus that allows the controller to have bi-directional communication with the CPLDs and the RF Sense FPGAs. In various embodiments, the FPI provides SPI interface between the controller and connected devices through an ABDI connector to communicate with the FRAM on the advanced bipolar devices. FPI also provides electrical isolation for low voltage signals from between controller and the ABDI. The device interface on the ABDI is configured to transmit RF energy to the connected device along with SPI communication. In one embodiment, the ABDI connects a signal from a device that indicates it is connected.

The FPI-ABDI interface provides power to the devices that connect to the generator, SPI communication between controller and the devices, device switch signals from the devices to the controller, and device connected signals from the devices to the controller. ABDI provides the RF energy to each connected advanced bipolar device through a separate pogo pin array. The FPI provides signal, low voltage power and high voltage RF power from the FPI and RF Amplifier to the connected device through the ABDI connector via the pogo pin array.

Referring now also to FIG. 5, the RF amplifier comprises a transistor H-bridge circuitry in which pairs of transistors are switched on and off in accordance with a pulse width modulation signal from a pulse width modulation and fault detection circuitry 31 to generate a sinusoidal signal from DC voltage supplied to the RF amplifier. The RF energy is supplied to the electrosurgical instrument via device ports 45. The sinusoidal signal is filtered by filter circuitry 32 and communicated to the connected and active electrosurgical instrument by switching and tissue measure circuitry 33. Voltage, current, power, phase and other measured/calculated information is determined by a voltage and current sense circuitry 34 in conjunction with the RF sense 43. In one embodiment, the generator includes a relay matrix which selectively switches or steers the RF energy from the RF amplifier to one of the device ports. In one embodiment, the switching and tissue measure circuitry 33 includes a low voltage network analyzer circuit used to measure instrument and/or tissue impedance before RF power is turned on. If successful, e.g., no short or open is detected for an electrosurgical device, RF energy is switched and thus the RF amplifier 42 supplied RF energy to one of the device ports 45.

The RF amplifier 42 in one embodiment receives voltage and current set points, which are input by the user through a user interface, to set the output level of the RF amplifier. The user sets points are translated into operating levels by digital to analog converters of the RF amplifier. The set points in one embodiment include a maximum voltage output, maximum current output, and a maximum power output. In accordance with various embodiments, the RF amplifier provides the RF energy based on one or more of these set points, such as providing the output voltage of the RF amplifier so that one or more of the set points are not exceeded.

The RF Amplifier in accordance with various embodiments manages the DC to RF conversion process as well as certain system electrical measurements. Switching and tissue measure circuitry routes RF transformers or measurement components to the output electrodes. In accordance with various embodiments, volt-ampere (VA) is the unit used for the apparent power provided by the generator and is equal to the product of root-mean-square (RMS) voltage and RMS current. In direct current (DC) circuits, this product is equal to the real power (active power) in watts. Volt-amperes are useful in the context of alternating current (AC) circuits (sinusoidal voltages and currents of the same frequency). Volt-amperes and watt have a dimension of power (time rate of energy), but are still different.

The controller FPGA has direct control of the RF output relays. The output relay configuration determines which drive signal (RF or tissue measure) is routed to which device port, either device port 1 or 2 as shown in FIGS. 5-1 and 5-4. During calibration they can also connect to a predetermined load, e.g., a resistor having a set value, across the tissue measure analyzer to calibrate it before connecting the device load (load of the connected electrosurgical instrument in contact with tissue). The RF output relays are located by or incorporated into the RF Amplifier 42.

In accordance with various embodiments, the controller generates a pair of Device 1 Relay control signals for Device 1 relay pair 61 to connect the RF energy bus to the device 1 port. In a similar manner, the controller generates a pair of Device 2 Relay control signals for Device 2 relay pair 62 to connect the RF energy bus to the device 2 port. The RF Amplifier relay pair 63 controls whether the RF amplifier output is connected to the RF energy bus and the Tissue Measure relay pair 64 controls whether the Tissue Measure analyzer is connected to the RF energy bus. The RF amplifier and Tissue Measure analyzer are sources to the RF energy bus, and the device ports are destinations for the selected energy. The Tissue Measure Calibration relay 65 connects the predetermined calibration load across the RF energy bus.

As such, in accordance with various embodiments are used to direct the flow of RF energy or the output of the tissue measurement circuit to one of the device ports. Four pairs of relays signals control four pairs of relays that change the flow of energy through the system. A first relay pair allows for the high power RF signals to flow to the ABDI 47 and eventually through the connected device. A second relay pair allows for the tissue measure circuit to send and measure signals from the devices via the ABDI. A third and fourth relay pair allow for the signal, whether being the high power RF signals or the tissue measure signals to flow to either Device 1 or Device 2 via the ABDI. The signals that control the relays are controlled by the Controller 44.

The calibration signal controls a fifth relay that allows the tissue measure circuit on the controller to measure a predetermined load 66. The input signals to the relay circuits, which are HIGH when the relays are open, are inverted by inverters. The output to the inverters is connected to MOSFETs, which controls the relay. When a relay must be closed, the input to the relay circuit goes LOW, which causes the output of the inverter, and thus the input to the MOSFET, to go HIGH. When the input of the MOSFET is HIGH, this allows 5V to flow through the coil, closing the relay and allowing signals to pass through. The relays are open and closed in a certain order or sequence, which is determined by the controller.

In accordance with various embodiments, a Device 1 Active signal is asserted when the relays are configured for RF or Tissue Measure energy on device port 1, a Device 2 Active signal is asserted when the relays are configured for RF or Tissue Measure energy on device port 2, and Device 1 and Device 2 RF On signals are active only when the RF amplifier is ON and the relays are in the RF Energy on Device 1 or RF Energy on Device 2 configurations, respectively.

The controller FPGA controls the RF amplifier based on settings provided by the microcontroller. In one embodiment, the settings from the microcontroller are set by a script file retrieved from memory attached to a connected electrosurgical instrument. The microcontroller in one embodiment sets the desired voltage, current and power levels and enables an RF amplifier output.

In one embodiment, a low power buffered voltage-out DAC provides the set values for Voltage, Current and Power to the control loop and error amplifier. The control loop or system is illustrated in FIG. 5-5. The voltage, current, and power feedback voltages 84, 85 and 86 go through a filter which is shown as a gain stage 87. This filtered feedback is summed 88 with respective set point parameters and each error is then integrated through a circuit 89 that was tuned for each parameter. All of the error outputs junction together with diodes 80 so that the lowest output controls the PWM circuit 90.

Each of the low-passed voltage, current and power feedback signal and the inverted set voltage, current and power signals (VSET 81, ISET 82, and PSET 83) pass through a resistor and combine together to make a signal with amplitude of (FVltFBT−Vset)/2, (FCurFBT−Iset)/2, and (FPwrRBT−Pset)/2 which are considered as an error signal in each control loop. The next stage is a proportional-integral controller (PI) that produces a DC signal (VError, IError, PError) as the result of error signal changes at its input. VError, IError, PError are used at a summing junction to define which one of voltage, current or power are in the control of the main control loop to force certain PWM duty cycle for RF amplifier 42.

Referring also now to FIG. 6, RF sense 43 comprises a synchronous detector that samples the RF energy being supplied to the electrosurgical instrument. The RF sense removes unwanted harmonics of the RF energy by multiplying the supplied RF energy to a reference signal or signals. From the signal product, the RMS voltage, RMS current, apparent power and phase information can be calculated. The RF sense includes ADC circuitry 36, isolation components 37, an FPGA 38 and a DAC 39. Real and imaginary components of raw current and voltage data are determined via the Analog to Digital circuits and these components that provided to an FPGA 38 via isolation barriers or components 37 for processing of the components. In the illustrated embodiment, two device channels are provided for two advanced bipolar electrosurgical tool ports and the associated instruments. Fault detection data 35 is supplied via the FPGA 38 and digital forms of measured or calculated voltage, current, power and phase are provided by the DAC circuitry 39. In one embodiment, the FPGA is responsible for signal conditioning of feedback signals from the synchronous detector and is also responsible for detecting faults.

The ADCs 36 simultaneously sample the output of the synchronous detector, which represent the real and imaginary values for the voltage and current of the output signal on each device port. After they sample, the FPGA stores these values in an ADC control module. An ADC error correction module pulls this data from the ADC control module via a multiplexer to correct sample errors by applying offset and gain corrections.

The output of the ADC error correction module is a representation of the real and imaginary components of voltage and current from both an active and inactive device port. The output of the ADC correction module also outputs a sign bit for each signal from the active device port for phase calculation. A separate module takes the real and imaginary values for the voltage and current from the active device port and computes the RMS voltage, RMS current, and apparent power magnitudes and the phase between voltage and current. Once these values are computed, the DAC error correction module applies offset and gain corrections to the scaled and signed representation of each signal. DAC error correction for voltage, current, power, and phase is done sequentially. The data is sent to the DAC controller module. The DAC controller module sends out data to the DACs.

The FPGA 38 monitors the real and imaginary values for voltage and current and generates fault codes if their values deviate beyond a specific threshold on the inactive device port. Additionally, if the phase relationship between the synchronization signals is lost, the FPGA will generate a fault code. The synchronization monitor module has four inputs that are always 180 degrees out of phase from each other. This module monitors for valid time relationships between the signals and flags an error if there is a violation.

In accordance with various embodiments, the RF sense FPGA is configured to correct for errors in RF feedback signals and calculate the magnitude and phase of these signals. A synchronous detector of the RF Sense uses synchronization signals generated by the controller FPGA to generate in-phase (real) and quadrature (imaginary) components of the voltage and current feedback signals from the RF Amplifier. The RF sense FPGA monitors the phase relationship between synchronization signals generated by the controller and asserts a fault when the phase relationship is out of order.

In accordance with various embodiments, a plurality of synchronization signals are used as clock inputs for RF Sense. The synchronization signals have the same duty cycle and frequency. The only difference between the signals is their phase relationship. For example, in one embodiment, a first synchronization signal is used as a reference and the second synchronization signal is identical to first synchronization signal but is delayed by 180 degrees. A third synchronization signal is delayed from first synchronization signal by 90 degrees and a fourth synchronization signal is delayed from first synchronization signal by 270 degrees. The clock edges provided by these four signals provide the exact timing required by the RF Sense for proper sampling of the RF output signal.

In accordance with various embodiments, the electrosurgical generator measures RF output voltage and current. Due to the electrosurgical nature of the generator, however, it is required that the measurements be done using isolated circuitry. Voltage measurement can be simple because the signal to noise ratio is relatively high. Current measurement using a current transformer however is problematic since there is a significant level of PWM output stage switching noise present in the circuit and isolation of typical current transformer cannot suppress this noise enough for the desired or required accuracy. Sampling the output voltage and current directly by using secondary side referenced (floating) Analog to Digital Conversion (ADC) and a shunt resistor can also create a different problem.

PWM switching noise is not harmonically related to the fundamental PWM carrier frequency and has a wide bandwidth. This noise can be overcome by significantly over-sampling the signal in order to achieve a desired or necessary accuracy. However, with a 350 kHz PWM carrier frequency, 64 times over Nyquist sampling frequency and 12-bit resolution, the required speed of the digital stream is 5.376×10⁸bits/s, per ADC channel. ADCs and digital isolators with this performance are difficult to source and relatively expensive.

In accordance with various embodiments, by using an accurate analog preprocessor the frequency requirements for the digital stream can be lowered. The analog preprocessor utilizes the fact that change of the RF output voltage and current in time is relatively slow and in general, the useful bandwidths of those signals are narrow.

In one embodiment, the analog preprocessor comprises a synchronous detector which allows transfer of the RF signal spectrum from the area concentrated around the carrier frequency down to zero. The narrowed bandwidth significantly simplifies the complexity for the ADCs and digital isolators. As such, ADC sampling frequency can be low and digital isolator throughputs are reduced. Digital isolator coupling capacitance is also reduced due to reduced or minimal number of parallel channels. In general, processing speed requirements are reduced which leads to lower cost components.

Referring to FIGS. 6-1 to 6-4, in accordance with various embodiments, a synchronous detector comprises an analog multiplier, which defines overall accuracy of the circuit. However, due to the presence of off-band PWM noise and/or a 350 kHz carrier frequency existing analog multipliers will not satisfy an accuracy requirement of 0.5% or better.

A local oscillator (LO), which is required for spectrum transform, can be non-sinusoidal. If the number of gain levels present in such a waveform is limited, an analog multiplier can be implemented using analog switches instead of a multiplier.

In one embodiment, as shown in FIGS. 6-1 to 6-2, the LO waveform 95, 96 utilized is a square wave where gain 91, 92 can be either +1 or −1. Low pass filters (LPF) 93, 94 at the outputs of switches are used for averaging and to suppress conversion components with high frequencies. The input signal 97 of the synchronous detector can be defined as the fundamental frequency:

$ω = \frac{2 π}{T}$

where T is defined as the fundamental period, A is the fundamental amplitude and p is the fundamental phase. The 3^rdharmonic frequency can be defined as:

$3 ω = \frac{6 π}{T}$

where kA is defined as the amplitude of the 3^rdharmonic frequency, k is the ratio of the 3^rdharmonic amplitude over fundamental, and q is the phase of the 3^rdharmonic frequency. Real (Re) and Imaginary (Im) output voltages of the synchronous detector are as follows:

$Re = \frac{A}{T} {- \int_{- \frac{T}{2}}^{- \frac{T}{4}} (\cos (\frac{2 π t}{T} + p) + k \cos (\frac{6 π t}{T} + q)) dt + \int_{- \frac{T}{4}}^{\frac{T}{4}} (\cos (\frac{2 π t}{T} + p) + k \cos (\frac{6 π t}{T} + q)) dt - \int_{- \frac{T}{4}}^{\frac{T}{4}} (\cos (\frac{2 π t}{T} + p) + k \cos (\frac{6 π t}{T} + q)) dt) = \frac{A}{6 π} (- 3 \sin p + 3 \cos p - k \sin q - k \cos q) + \frac{A}{6 π} (6 \cos p - k \cos q) + \frac{A}{6 π} (3 \sin p + 3 \cos p + k \sin q - k \cos q) = \frac{A}{6 π} (4 \cos p - k \cos q)$

$Im = \frac{A}{T} {- \int_{- \frac{T}{2}}^{0} (\cos (\frac{2 π t}{T} + p) + k \cos (\frac{6 π t}{T} + q)) dt + \int_{0}^{\frac{T}{2}} (\cos (\frac{2 π t}{T} + p) + k \cos (\frac{6 π t}{T} + q)) dt) = \frac{A}{3 π} (- 3 \sin p - k \cos q) + \frac{A}{3 π} (- 3 \sin p - k \cos q) = - \frac{A}{3 π} (6 \sin p + 2 k \sin q)$

In the case that only the fundamental frequency is present in the input signal spectrum (k=0), complex amplitude can be calculated as follows:

$Mod = \frac{2 A}{π}$

$Arg = Atan \frac{- \sin p}{\cos p}$

If the amplitude of the 3^rdharmonic is not equal to the zero, the complex amplitude can have a different result.

Referring now to FIGS. 6-3 to 6-4, in accordance with various embodiments, a complex LO 3-level waveform 98, 99 generated by a 3-level waveform local oscillator can be used. By using the LO 3-level waveform, real and imaginary output voltages become independent on the presence of the 3^rdharmonic, but can be distorted if higher order harmonics are present. Real (Re) and Imaginary (Im) output voltages of the synchronous detector are as follows:

$Re = \frac{A}{T} {- \int_{- \frac{T}{2}}^{- \frac{T}{3}} (\cos (\frac{2 π t}{T} + p) + k \cos (\frac{6 π t}{T} + q)) dt + \int_{- \frac{T}{6}}^{\frac{T}{6}} (\cos (\frac{2 π t}{T} + p) + k \cos (\frac{6 π t}{T} + q)) dt - \int_{\frac{T}{3}}^{\frac{T}{2}} (\cos (\frac{2 π t}{T} + p) + k \cos (\frac{6 π t}{T} + q)) dt) = \frac{A}{12 π} (- 3 \sin p + 3 \sqrt 3 \cos p - 4 k \sin q) + \frac{A \sqrt 3}{2 π} \cos p + \frac{A}{6 π} (3 \sin p + 3 \cos (p + \frac{π}{6}) + 2 k \sin q)$

Because

$\cos (p + \frac{π}{6}) = \frac{1}{2} (\sqrt 3 \cos p - \sin p)$

then

$\frac{A}{6 π} (3 \sin p + 3 \cos (p + \frac{π}{6}) + 2 k \sin q) = \frac{A}{12 π} (6 \sin p + \sqrt 3 \cos p - \sin p + 2 k \sin q) and Re = \frac{A \sqrt 3}{π} \cos p$

$Im = \frac{A}{T} {- \int_{- \frac{5 T}{12}}^{- \frac{T}{12}} (\cos (\frac{2 π t}{T} + p) + k \cos (\frac{6 π t}{T} + q)) dt + \int_{\frac{T}{12}}^{\frac{5 T}{12}} (\cos (\frac{2 π t}{T} + p) + k \cos (\frac{6 π t}{T} + q)) dt) = - \frac{A \sqrt 3}{2 π} \sin p - \frac{A \sqrt 3}{2 π} \sin p = - \frac{A \sqrt 3}{π} \sin p$

In this case, the complex amplitude is as follows:

$Mod = \frac{A \sqrt 3}{π}$

$Arg = Atan \frac{- \sin p}{\cos p}$

Therefore, the dependence on the presence of 3^rdharmonic of any level is eliminated. In accordance with various embodiments, the symmetrical nature of a RF amplifier creates signals with naturally low levels of even harmonics. Low pass filters in one embodiment also suppresses high frequency PWM carrier components and is capable of suppression of 5th harmonics to sufficiently low levels. Further examples of the synchronous detector's operation are provided by exemplary signal waveforms at the respective outputs (SynchDetRe and SynchDetIm) prior to filtering by the low pass filter 93 for an exemplary input signal (Uin=cos ωt) are also shown in FIGS. 6-5 to 6-6. FIG. 6-7 provides an exemplary signal waveform illustrating an input signal phase shifted (e.g., Uin=cos(ωt+π/4)) and likewise exemplary signal waveforms at the respective outputs (SynchDetRe and SynchDetIm) prior to filtering by the low pass filter 93 for such an input signal are shown in FIGS. 6-8 to 6-9. FIG. 6-10 provides an exemplary input signal that is significantly corrupted but has no harmonics higher than 4^thharmonics and likewise exemplary signal waveforms at the respective outputs (SynchDetRe and SynchDetIm) prior to filtering by the low pass filter 93 for such an input signal are shown in FIGS. 6-11 to 6-12. As such, as illustrated, the synchronous detector in accordance with various embodiments can accurately recover the fundamental amplitude and phase of such input signals and thus accurately provide Real (Re) and Imaginary (Im) output voltages for the detection and measurements or calculations of phase and/or rate of changes of phase.

Referring now to FIGS. 7 and 8, the controller 44 includes RF smoother or smoothing modules or circuitry 68 to remove noise and/or extrapolate a smooth modulated DC signal representative of the RF energy being outputted (e.g., voltage, current, power and/or phase). An exemplary RF energy before and after the RF smoother are shown in FIGS. 19-20. In one embodiment, a data sampler 69 collects raw, evenly spaced data values from the analog to digital (ADC) phase, voltage, current, and power channels as the measurements are taken, then the RF smoother 68 applies a smoothing algorithm to filter the raw values into the resulting smoothed values. Further analysis is performed to determine various points of interest or events, such as the phase minimum and zero crossing points. Those points of interest are passed to the event handler 67 to trigger state changes. The generator in one embodiment waits for specific points of interest or events to be reached before changing states.

In one embodiment, the RF smoother 68 detects the local minimum point in the smoothed phase data provided by the RF Smoother and this point of interest is passed to the event handler 67 that notifies the script operations engine 65. In one embodiment, the RF smoother detects the zero crossing indicated for example by an ADC reading equal to about half of the maximum ADC counts and this point of interest is passed to the event handler that notifies the operations engine 65. Input and output commands, interrupts and event detections are provided by a query/command interface 66.

In accordance with various embodiments, the operations engine 65 enables the generator to be configurable to accommodate different operational scenarios including but not limited to different and numerous electrosurgical instruments, surgical procedures and preferences. The operations engine receives and interprets data from an external source to specifically configure operation of the generator based on the received data.

The operations engine receives configuration data from a device database script file 101 that is read from a memory device on a device plug or key 102. The script defines the state logic used by the generator. Based on the state determined and measurements made by the generator, the script can define or set output levels as well as shutoff criteria. The script in one embodiment includes trigger events or indicators that include indications of short condition for example when a measured phase is greater than 70 degrees or an open condition for example when a measured phase is less than −50 degrees.

In one embodiment, the operations engine provides system states and user states. System states are predefined states that control or manage specific predefined operations or operation conditions of the generator, such as successfully applying RF energy or indicating an error. System states in one embodiment are a pre-defined set of configurations that the system can be in (e.g., idle vs. energized) and whose functions are hard-coded into the electrosurgical generator. For example, a RF Done state is a system state that indicates that an RF energy cycle has been completed without errors. User states provide a framework through which customized or specialized operations and values can be established by direction from an external source for a particular instrument, procedure and/or preference.

In one embodiment, the script sets forth the system states and their exit conditions, e.g., expiration times or directions to another state and where the user states begin. For each user state, operation parameters for the specific state can be defined such as power, voltage, and current settings or are carried over from a previous state. In one embodiment, the user states may provide device, operator or procedural specific states and in one embodiment, the user states may be provided for testing or diagnostics specific states.

An exemplary two user state process is shown as an example in FIG. 10. The process begins in a system state Idle (71). If the switch is pressed (asserted) (78), the generator transitions to the User State 1 (72). Based on the exit condition, the generator transitions to the next state, User State 2 (73) or one of the system states (e.g. RF_Done (74) or Error (75)). If there is no user state after User State 2, then the process transitions back to a system state other than the system state Idle which will then transition the generator back to the system state Idle.

The exit criteria or condition (79) for each state defines the logic path for the script based on measurements made by the generator and thus the generator transitions from user state to user state. However, if the exit condition does not match the expected logic path, the seal or operation cycle is considered to have not been successfully completed, and the system state Error (75) is achieved. If the exit condition does match the expected logic path or indicates completion of an operation cycle, the operation cycle is considered to have been completed successfully, and the system state RF_done (74) is achieved. In one embodiment, if the switch is released before the completion of the fuse cycle, the system state Switch_Release (76) is achieved. In accordance with various embodiments, additional system states can be predefined to handle other general system errors or unexpected deviations from the expected logic path such as a timeout state indicating a maximum time to complete a fuse or operation cycle has been exceeded. Additionally, although only two user states are shown, the generator is expandable and configurable to include additional user states to provide an expanded logic path for a particular or a range of electrosurgical instruments, procedures and/or preferences.

Through the scripts, individual parameters or conditions pertaining to the electrosurgical or fusion process may be set. For example, acceptable impedance levels for an electrosurgical instrument prior to RF energy activation, maximum voltage, current and power settings (and in one embodiment, for each corresponding user adjustable level settings (e.g., level 1-3)), switch assert and de-assert dwell times for activation and deactivation, and stuck button error times at initial connection and following the completion of an operation cycle.

In one embodiment, the operations engine provides at least 30 states, 5 system states and 25 user states that provide the operational control parameters and output characteristics. These characteristics define the voltage, current and power output ranges that can be the full scale of the generator's output ranges or any level below. Each state in one embodiment has the ability to provide operation conditions such as to enable or disable RF output, modify the RF output regulation levels, as well as recognize and act upon different events or control indicators based on for example time, voltage, current, power, or phase (ϕ) or combinations of these values and transition to another user state, error state, or completion state. The data, in one embodiment, that the operations engine receives from the event handler or the RF smoother has been smoothed according to a double exponential smoothing algorithm or exponential moving average algorithm. Voltage, current, power and phase smoothing parameters can be set individually in the device script.

In one embodiment, every 1 ms, the data sampler reads and stores the ADC channel measurements, e.g., voltage, current, power and phase angle. After the ADC measurements are processed, the data sampler calls the RF smoother. The RF smoother smooths or filters the ADC measurements and then notifies the event handler. If the event handler (checking for example every 15 ms) finds that a specific event or indicator has occurred, the event handler notifies the operations engine 65. After the operations engine has processed the event, it sets up the event handler for the next series of event evaluations.

The event handler in one embodiment is configured to evaluate a set of script events as defined by the device script. A script event is a grouping of postfix (Reverse Polish Notation (RPN)) tokens which describe a Boolean equation. The operations engine 65 provides the event handler with a port corresponding to a device script database and with a script state 68. The event handler evaluates that state and each event in that state in which each event is described by a Boolean equation. The event handler calculates the value of the Boolean equation. If any event evaluation in the state is found to be true, the event handler notifies the script operations engine, indicating that an event in the particular state was encountered, and providing the next location in the device script database where the script is to continue execution. If no event is found, then the event handler does not notify the script operations engine. In one embodiment, the event handler is configured to evaluate up to 10 events per a given sample time in which events are evaluated sequentially.

The event handler obtains timer values from a system timer 70 and switch events (press, release) 72 from a connected device and simulated switch events from the diagnostic port 71. The event handler also checks for time based events, such as a global timeout or state timeout and other recoverable errors such as over-voltage or over-current conditions. In one embodiment, this check is done by reading and comparing various ADC values to limits set by the device script.

The operations engine in one embodiment receives and installs the device script database file into a predefined device script database storage location in memory. During script development, the script compiler compiles the script source file into the device script database, containing among other things event data stored in RPN notation and state instructions. Prior to installation, the operations engine checks the device script database, i.e., the compiled script, for errors. In one embodiment, operations engine checks each token in the RPN data for values “out of range”, that a Boolean value is returned and that there is only one RPN token remaining on the stack when the token count is at the end of the RPN data.

Referring now to FIG. 9, in accordance with various embodiments, a device is plugged into the tool port of the generator. The operations engine authenticates the device, which indicates that the integrity of the device memory and script has not been compromised. If the device passes authentication, the operations engine verifies the script database, which indicates that the script database was built correctly. If the script database is verified as valid, the operations engine begins script execution. (The start section of the IDLE state is set as the row number in the script table to begin running at.)

In operation, the operations engine reads commands from the script database. When the operations engine must wait for an event, the operations engine instructs the event handler with which events to identify and waits. When an event is identified by the event handler, i.e., event evaluation is true, the event handler notifies the operations engine and the event handler is disabled from further event evaluation for the tool port until the operations engine commands the event handler again. In one embodiment, the event handler is interrupted from a timer at least once per 20 ms or from ADC data being to evaluate events. The operations engine resumes execution when it is notified by the event handler that an event has been triggered.

The fusion process could be terminated (a) at a fixed and absolute resistance (for example 2 k Ohms), which would neglect both the size and type of tissue, (b) at a specific multiple of the time where the ohmic resistance is minimal, (c) at a specific multiple of the time where the ohmic resistance is the same as the initial one, or (d) at a specific multiple of the time where the ohmic resistance is a certain factor of the minimal one. However, considering burst pressure of fused arteries and thermal spread, the termination of the fusion process is determined to be in the flattened part of the impedance curve. As can be seen in FIGS. 12-20, however, this region is also an inexact range for impedance measurements. Similarly, each succession of (a) to (d) becomes better in determining the end-point of the fusion time (resulting in the highest desired bursting pressure with the least desired thermal spread). Utilizing the ohmic resistance only as termination criterion can lead to incomplete results. This can be more pronounced when fusing differently sized tissues (even of same nature).

In one aspect, the determination of the end-point of the fusion process is given by monitoring the phase shift of voltage and current during the fusion process. Unlike impedance, the phase shift changes much more pronounced at times where fusion of tissue completes, and hence offers a more sensitive control value than the impedance. However, for various types of tissue, reaching a high end of the phase range can lead to excessively long fusing times. Accordingly, as will be described in greater detail below, the application of RF energy via an electrosurgical generator in conjunction with the measuring or monitoring of phase shift are provided to fuse vessels and tissue in accordance with various embodiments of electrosurgical system.

As such, the instrument generating the seal, fusion or connection of the tissue provides atraumatic contact to the connecting tissue and provides enough burst pressure, tensile strength, or breaking strength within the tissue.

In one embodiment, the generator initially determines the initial instrument impedance and/or capacitance (e.g., during plug-in of the instrument connector to the electrosurgical generator), where tolerances/changes in the instrument characteristics are then accounted for in the tissue measurement and endpoint determination process. This can allow for tissue measurement values which are independent of the ohmic and capacitive values and/or tolerances of a specific electrosurgical instrument.

Exemplary RF energy control process for the electrosurgical generator and associated electrosurgical instrument for fusing tissue in accordance with various embodiments are shown in FIGS. 11A-11B. In one embodiment, RF energy is supplied by the generator through the connected electrosurgical instrument or tool (101). The generator monitors at least the phase and/or change of phase of the supplied RF energy (102). If a phase zero crossing or polarity change from positive to negative or negative to positive is encountered (103), a phase stop is determined (104). The phase stop in one embodiment includes a predefined phase angle and/or change of phase angle based on a determined tissue property such as size, permittivity, conductivity and/or applied voltage, current and/or power. The generator continues to monitor at least the phase and/or change of phase of the supplied RF energy (106). If the phase stop (105) is reached or exceeded, the process is done or termination procedures are initiated and/or RF energy supplied by the generator is stopped (107).

In one embodiment, prior to the start of the process, impedance is measured to determine a short or open condition through a low voltage measurement signal delivered to a connected electrosurgical instrument. In one embodiment, a passive impedance measurement is used to determine if the tissue grasped is within the operating range of the electrosurgical instrument (e.g., 2-200Ω). If the initial impedance check is passed, RF energy is supplied to the electrosurgical instrument. In one embodiment, voltage of the RF energy is applied (111) in a ramping fashion starting from 25% to at most 80% of a global setting or, in one embodiment, an user selected level (e.g., 27.5-88V for level 1, 25.0-80V for level 2 and 22.5V-72V for level 3).

Voltage and phase of the applied RF energy are continuously measured (112). When the phase measurement equals zero or transitions from positive to negative (113), voltage at that point is held constant at that voltage or at a predetermined voltage. In one embodiment, the zero or polarity crossing is used to determine the size of the tissue and select the appropriate path for completing the fusion cycle. In one embodiment, the voltage level of the ramp at the zero-crossing is used to determine the size of the tissue and then the appropriate path. It has been noted that the time taken to reach the phase zero-crossing can be associated with or correlate to the amount of water or moisture being removed from the tissue at that point and the tissue size.

In accordance with various embodiments, if the voltage level is less than 50% of the selected level at the phase zero-crossing (e.g., level 1: voltage<55V; level 2: voltage<50V; level 3: voltage<45V), tissue size is determined to be small (114). If the voltage level is less than 60% and greater than 50% of the selected level at the zero-crossing (e.g., level 1: 55 V<voltage<66 V; level 2: 50 V<voltage<60V; level 3: 45V<voltage<54V), tissue size is determined to be medium (115). If the voltage level is greater than or equal to 60% of the selected level at the zero-crossing (e.g., level 1: voltage≥66 V; level 2: voltage≥60V; level 3: voltage≥54V), tissue size is determined to be large (116). Based on the tissue size determination being medium or large, the voltage of the applied RF energy is held constant at the level at the zero-crossing. In accordance with various embodiments, based on the tissue size determination being small, the voltage of the applied RF energy is set to a predefined voltage and in one embodiment is set to 22 V. The predefined voltage in one embodiment is less than the voltage level based on the tissue size determination being medium or large.

If the monitored phase and/or change of phase equals or is less than the selected predetermined phase and/or change of phase, electrosurgical energy is stopped (121). In one embodiment, if the calculated phase does not reach this phase stop within a set time, e.g., three, three and quarter or 4 seconds, electrosurgical energy is stopped. In one embodiment, if tissue size is determined to be small, the phase stop and/or change of phase stop is set to phase<−7.0° and/or change of phase<−2.3°/s (117). An exemplary graphical representation of RF energy successfully fusing tissue with a tissue size determined to be small is shown in FIG. 12. Also, as illustrated, phase 12b is shown relative to other tissue readings or indicators such as current 12a, power 12c, impedance 12d, temperature 12e, energy 12f and voltage 12g. If tissue size is determined to be medium, the phase stop and/or change of phase stop is set to phase<−23.0° and/or change of phase<−7.1°/s (118). An exemplary graphical representation of RF energy successfully fusing tissue with a tissue size determined to be small is shown in FIG. 13. Also, as illustrated, phase 13b is shown relative to other tissue readings or indicators such as current 13a, power 13c, impedance 13d, temperature 13e, energy 13f and voltage 13g. If tissue size is determined to be large, the phase stop and/or change of phase stop is set to phase<−32.0° and/or change of phase<−8.0°/s (119). An exemplary graphical representation of RF energy successfully fusing tissue with a tissue size determined to be small is shown in FIG. 14. Also, as illustrated, phase 14b is shown relative to other tissue readings or indicators such as current 14a, power 14c, impedance 14d, temperature 14e, energy 14f and voltage 14g. Additionally, although shown in FIGS. 12-14, in various embodiments, the generator is configured to not measure or calculate one or more of the indicators or readings, e.g., temperature or energy, to reduce operational and power parts, costs and consumptions of the generator. The additional information or readings are generally provided or shown for context purposes.

In accordance with various embodiments, phase is monitored in conjunction with current for open and short events while RF energy is being applied and in one embodiment after phase and/or change of phase stop or endpoints is reached to evaluate or determine if a false indication of fusion (caused by an open or short) has been reached.

In accordance with various embodiments, the generator is configured to provide additional regulation of various parameters or functions related to the output of the RF energy, voltage, current, power and/or phase and the operations engine is configured to utilize the various parameters or functions to adjust the output of RF energy. In one exemplary embodiment, the control circuitry provides additional regulation controls for direct regulation of phase in which voltage, current and/or power output would be adjusted to satisfy specified phase regulation set points provided by the operations engine.

In accordance with various embodiments, the generator utilizes the measured values of voltage, power, current and/or phase, e.g., control indicators, to recognize and act or perform operation conditions. In various embodiments, additional measurements or calculations based on the measured values related to RF output regulation circuitry are provided by the script or operations engine to recognize and act upon additional or different events related to or trigger by the additional measurements or calculations relative to other measurements or thresholds. The additional measurements in one embodiment include error signals in combination with a pulse width modulation (PWM) duty cycle used to regulate the output of voltage, current and/or power or other similar regulation parameters. Different or additional events or indicators that could be identified and triggered in various embodiments could be transitions from one regulation control to another regulation control (e.g. current regulation to power regulation).

In accordance with various embodiments, the generator provides or conducts calculations to directly measure the rate of change of voltage, current, power and/or phase. For example, FIG. 15 provides exemplary graphical representation of phase 15a of the RF energy in relation to change of phase of RF energy 15b. The generator in one embodiment based on these calculations or direct measurements can recognize and act upon different events related to the RF output and electrical characteristics of the tissue during a fuse cycle.

In accordance with various embodiments, the predetermined completion indicator can be varied or modified by the operations engine. In one embodiment, during a given fuse cycle, a tone (or other indicator) sounds at a phase threshold that is determined to be equivalent to a 7 psi (3×systolic pressure) seal 161 and then RF energy continues to be applied to the vessel to a phase threshold that is determined to be equivalent to a higher burst pressure (e.g. 20 psi) 163 at which point RF energy is automatically terminated. An exemplary graphical representation of RF energy fusing tissue utilizing seal pressure determinations is shown in FIG. 16. Also, as illustrated, phase 16g is shown relative to other tissue readings or indicators such as voltage 16a, power 16b, impedance 16c, energy 16d, temperature 16e and current 16f. In accordance with various embodiments, instead of or in addition to phase angle being used as a predetermined completion indicator or for other thresholds, time, voltage, current and power as well as conditional combinations thereof could be used.

In one embodiment, the user can release the activation button at any time between the initial tone and the end tone. This provides the surgeon with some degree of control with regards to the amount of RF energy is being applied to the tissue. For example, for thin, non-vascular tissue, a surgeon may release the button closer to the initial tone rather than wait for a subsequent tone. Similarly, for larger tissue, a surgeon may release the button much later than the initial tone or closer to a subsequent or end of cycle tone to thereby continue to apply RF energy longer.

In one embodiment, phase angle setting is user accessible and adjustable. By adding a phase level setting parameter, the phase trigger thresholds could be tied to percentages or a multiple (positive or negative) of the phase threshold. As such, the user could adjust a fuse cycle time, e.g., shorter and longer fuse cycles (e.g., Level 1 (171), Level 2 (172), and Level 3 (173)).

Level 1
Level 2
Level 3

Phase Setting
30
60
90

Phase endpoint determined by script
10°
20°
30°

(e.g. 33%)

An exemplary graphical representation of RF energy fusing tissue utilizing user adjusted phase levels 171, 172, 173 is shown in FIG. 17A. Also, as illustrated, phase 17g is shown relative to other tissue readings or indicators such as voltage 17a, power 17b, impedance 17c, energy 17d, temperature 17e and current 17f.

An additional way for providing alternate endpoints or alternative RF output delivery paths is to provide additional or alternative script logic paths based on the output level settings. This could also adjust a fuse cycle time, e.g., shorter or longer seal cycles that are user adjustable (e.g., Level 1 (175), Level 2 (176), and Level 3 (177)). An exemplary graphical representation of RF energy fusing tissue utilizing additional or user level adjusted script logic paths 175, 176, 177 is shown in FIG. 17B. Also, as illustrated, phase 17g1 is shown relative to other tissue readings or indicators such as voltage 17a1, power 17b1, impedance 17c1, energy 17d1, temperature 17e1 and current 17f1. Additionally, although shown in FIGS. 16-17B, in various embodiments, the generator is configured to not measure or calculate one or more of the indicators or readings, e.g., temperature or energy, to reduce operational and power parts, costs and consumptions of the generator. The additional information or readings are generally provided or shown for context purposes.

As provided in various embodiments, the operations engine provides the ability for the generator to operate between two or more states 18e. State transitions can be triggered by time, voltage, current, power or phase 18a, 18b, 18d and could also be used for an exit state 18c. In one embodiment, keeping a running state count of how many states have been cycled through would be an additional trigger for exiting a particular state. Alternative fuse cycles could also be defined using additional states or state counts that could include for example the cutting of tissue depending on RF output levels and electrosurgical instrument geometry. An exemplary graphical representation of RF energy fusing tissue utilizing script states is shown in FIG. 18.

In accordance with various embodiments, the RF Amplifier is configured to convert a 100 VDC signal from a power supply to a high power sinusoidal waveform with a frequency of 350 kHz, which will be delivered to the ABDI and eventually the connected electrosurgical tool. The amplitude of this signal in one embodiment is determined by a duty cycle of a plurality of input signals from the controller.

The RF Amplifier in one embodiment is configured with circuitry to ensure that there is dead time between PWM signals to prevent the PWM signals from the controller to be both ON at the same time. A 1:2 transformer of the RF Amplifier provides isolation between the PWM signals driving an H-bridge and a two stage low-pass filter. The output of the filter is a continuous 350 Khz sinusoidal waveform. The RF Amplifier includes a plurality of relays that are set by the controller to direct the 350 Khz signals from the output of the filter circuit to the device ports of the ABDI.

The RF Amplifier in accordance with various embodiments includes a plurality of shunt resistors, e.g., two shunt resistors for each of the device port. Voltage and current are measured across the resistors and in one embodiment are provided to two independent RF Sense. Relays on the RF Amplifier are set by the controller FPGA to direct a tissue measure signal from the controller to the device ports. In addition, a transformer is provided to isolate the tissue measure signal from the device ports. Power supply control signals pass through the RF Amplifier to the controller and in one embodiment the RF Amplifier includes an over-current detection circuit to determine if current supplied exceeds a specific threshold and/or a voltage monitoring circuit to determine if voltage supplied exceeds a specific threshold. PWM signals, RF energy shutdown signals, RF Sense control signals and relay control signals are supplied from the controller to the RF Amplifier. RF Sense analog signals, various RF sense fault signals, power supply control signals, passive measurement signals and standby power signals are supplied from the RF Amplifier to the controller.

In one embodiment, the RF Amplifier includes gate drive circuitry that takes at least two, 180° out of phase, 350 kHz PWM signals from the controller, to create non overlapping PWM signals that are fed into gate drivers in a power stage to generate the output RF signal or energy. Non-overlapping signals prevent damage to components in the power stage. Before the signals enter the power stage they are isolated to separate a noisy power ground from a quiet signal ground. The PWM signals at the power stage are fed into the gate drivers which take lower power PWM signals and produce high current drive input signals to the MOSFETs.

The controller provides two PWM signals with a certain pulse width depending on the desired RF output. The H-Bridge topology utilizes at least four gate drive signals to drive MOSFETs in the circuit. These four signals are attained by generating inverted counterparts for the two PWM signals. In addition, the RF Amplifier prevent a pair of signals (i.e. a first PWM signal and an inverted/second PWM signal) to be HIGH at the same time. Having both signals HIGH at the same time may potentially cause a shoot-through condition which can potentially damage components of the generator.

Two RC circuits in one embodiment of the RF Amplifier ensure that there is a dead time where both signals are off. Similarly, the other pair of signals also has two RC circuits to ensure dead time. The RC circuits have a shorter time constants to account for propagation delays.

In one embodiment, signals that can stop the propagation of PWMA and PWMB (i.e. a first PWM signal and an inverted PWM signal) to the gate drivers independently are provided. For example, one such signal is generated by the controller FPGA and the other signal is generated by the microcontroller. The PWM signals continue to propagate through isolators which separate the noisy ground from the quiet ground, where all the high power switching circuit is referenced to. These signals control the gate drivers, which converts the lower power PWM signals and produce a signal with high enough current to force the MOSFETs into saturation. Resistor and diode circuits at the output of the gate drivers are tuned to achieve the desired rise and fall times.

PWM DAC SPI lines allow the controller FPGA to communicate with the PWM DAC. The PWM DAC uses a DAC with the SPI interface to create a 4.452 Volt output. This output passes through an op-amp buffer and then is switched at 700 kHz, 50% duty cycle to create a 700 kHz square wave. As such, the PWM DAC sets a DC level initially, e.g., at power up, that is switched at 700 kHz to create a square wave output. This signal is then fed to an integrator stage which results in a 700 kHz triangle wave at the output. In particular, the integrator circuit causes a slope proportional to the input voltage. The amplifier is the other half. This changes the square wave into a triangle wave. The output is a 700 kHz wave with a duty cycle proportional to the error output. This signal goes to the FPGA Combined PWM input and the FPGA alternates these pulses to create first and second PWM outputs that operate the FETs on the input side of the RF transformer.

In particular, by combining the resulting triangle wave with the error signals from an RF control loop, the resulting signal represents a pulse width modulated signal that is used to drive the RF amplifier. Since the RF amplifier includes a full H-bridge output stage, two drive signals, each 180 degrees out of phase with the other are used. The PWM Signal Controller in the controller FPGA takes in the combined PWM signal and splits it into two signals. During the first half of the 350 KHz output cycle the FPGA routes the combined PWM signal to the first PWM output, and the second PWM output is held at 0V. During the second half the FPGA routes the combined PWM signal to the second PWM output, and the first PWM output is held at 0V.

In one embodiment, the first and second PWM outputs which drive the RF amplifier are only enabled if the microcontroller has requested the RF energy to be ON, e.g., enabled the RF amplifier output. If fault is detected while RF energy is active or being supplied, the PWM signals can be immediately disabled and the microcontroller alerted.

The microcontroller is able to control the RF amplifier output level by sending the desired voltage, current and power levels to the controller FPGA. These levels or set points are used by an analog RF control loop circuit which regulates the output power of the amplifier to meet the set points.

The Power Stage Circuit is configured to take the PWM signals produced in the gate drive circuit and generate a continuous sinusoidal signal, which is passed off to a relay circuit. The PWM signals drive MOSFETs in the H-Bridge configuration. The output of the H-Bridge is connected to a 1:2 transformer via a decoupling capacitor and a fuse. The transformer isolates the +100V power supply from the energy output to the patient. The circuit operates such that a first state follows second state continuously to produce a rectangular pulse train with a 0V offset. When the first state occurs, current passes through the transformer and exits the transformer. This produces the positive portion of the resulting waveform. When the second state occurs, current moves through the transformer in the opposite direction. This produces the negative portion of the resulting waveform. When PWMA and PWMB are either HIGH or LOW at the same time, the resulting waveform goes to 0V. After the transformer, this signal is passed off to a two-stage LC filter to produce a continuous sinusoidal waveform.

The two-stage LC filter is a low pass filter designed to provide a 0 dB gain at 350 kHz. The load resistance is the resistance across the tissue being sealed. A series capacitor in one embodiment is placed in order to minimize the possibility of neuromuscular stimulation.

In various embodiments, the controller includes a microcontroller that is generally responsible for overseeing the RF energy configuration and activation and the user interface. The controller also includes a Field Programmable Gate Array (FPGA) that is generally responsible for supporting the microcontroller by proving access to analog data and supervising the control circuits. The controller in one embodiment also includes a plurality of complex programmable logic devices (CPLDs) for health monitoring.

The microcontroller in one embodiment has an interface to the FPI to provide a user interface and indicate fault conditions/alarms, an interrupt input that indicates that a fault condition has been detected and an interrupt input that indicates that a front panel switch has changed states. The controller FPGA has parallel access to analog and control data, access to the front panel switches and an output that indicates a change in their state, and access to Device 1 and 2 inputs and outputs. In one embodiment, the controller FPGA has an active serial configuration interface for programming the FPGA and, in one embodiment, is the master for a system SPI communication bus for read and write access to the controller CPLDs and the RF Sense FPGAs.

The controller FPGA provides an interface to the ADC circuit that measures feedback voltage, current, power and phase, reads voltage and current set points and errors. The voltage, current, power and phase feedback voltages are measured redundantly by two groups of ADCs powered by different voltage references. The controller FPGA controls a DAC circuit that generates analog set points for voltage, current, and power.

The controller FPGA provides a clock, SPI DAC interface, and 700 kHz switch signal for the triangle wave generator and an input for the 700 kHz PWM circuit that generates 350 KHz +/−350 Hz outputs to a driver circuit of the RF Amplifier. The controller FPGA also detects when a device is connected. In various embodiments, the controller FPGA detects and provides outputs that indicate which device is active and PWM sync signals that are 90° out of phase (sine and cosine) to the RF Sense. The controller FPGA in various embodiments has an output to the microcontroller that indicates that a fault condition has occurred and has outputs to control the output/tissue measure relays.

The controller in one embodiment includes an analog control circuit to provide closed-loop control of the RF energy output using DAC outputs as set points and top voltage, current, and power RF Sense outputs as feedbacks. The output will be a combined PWM input to the FPGA.

The controller in one embodiment has redundant Complex Programmable Logic Device (CPLD) circuits generally responsible for detecting error conditions and shutting off the output when they occur. Each CPLD circuit is configured to have an output that operates an independent circuit that disables the RF output (Gate Power Control circuitry). Additionally, each CPLD circuit is configured to have a digital representation (ADC) of the RF sense 1 and RF sense 2 voltage, current, power, and phase outputs from the RF Sense. If any of these signals exceed minimum or maximum limits the CPLD circuit will disable the RF output.

In one embodiment, the controller CPLDs control load switches that allow the controller to independently turn off supply voltage to gate drivers and eventually the supply of RF energy.

The controller includes a plurality of CPLDs for detecting faults/error conditions. The CPLDs monitor the same signals for redundancy. The analog inputs that come from RF sense, after passing through the filter stage, get multiplexed and the outputs are fed to ADCs. From there, the outputs pass to a digital isolator which is used a voltage level shifter. Output of digital isolators feeds directly into the CPLD's bidirectional I/O.

The CPLD detect differences between RF sense 1 and RF sense 2 analog voltages or values (voltage, current, power, and phase) obtained from a plurality of RF Sense circuitry, e.g., RF sense 1 and 2. When the magnitude of the difference between RF sense 1 and RF sense 2 is greater than a maximum error value, the CPLD generates a local fault. Examples of other faults are when either voltage or current feedback signals for the RF sense 1 or 2 exceed predetermined limits, when the phase relationship between the synchronization signals is not valid for the RF sense 1 or 2.

The controller in one embodiment includes a passive measure circuit that is configured to compute absolute impedance and phase of tissue in contact with the connected electrosurgical tool. The passive measurement circuit in one embodiment includes a calibration resistor circuit and is transformer isolated from the patient.

The controller includes passive measure circuitry that includes a plurality of sub-circuits; an impedance analyzer, a voltage reference, a low pass filter, and a measurement amplifier. This circuit is electrically isolated from the patient by a transformer and can be connected to a known value resistor for calibration.

The impedance converter and network analyzer has an AC output that set to 100 kHz and this output passes through a filter circuit that removes harmonics from the 100 kHz signal and provides a current source that can drive low impedance loads. The passive measure amplifier uses the impedance of the tissue as the feedback so that the output is proportional to the impedance of the tissue.

Referring to FIG. 9, the generator 10 receives script information from the electrosurgical device or instrument 20 when the device is connected. The generator uses this script information to define a number of states and the order of execution of the states.

The script source file or script information written by the device script author 100 and not resident on the instrument or the generator 10 is text or user readable. The script information is compiled using a script complier 105 to generate a device script database or binary file (SDB) 101. The script binary file is transferred by a device key programmer 107 to a memory module that is connectable or incorporated into the electrosurgical instrument 20 via a device key 102. As the electrosurgical instrument is connected to the electrosurgical generator, the generator authenticates the script binary file and/or the instrument (108). The generator validates the script binary file (109) and if validated the operations engine utilizes the script initiated by the actuation by the connected instrument (110). Script source file in one embodiment is a text file containing a device script that is specific for a specific electrosurgical instrument, generator and/or surgical procedure. The script source file for a device in one embodiment includes information containing parameters and a script (states, functions, events) for the electrosurgical generator and/or electrosurgical instrument. After successful validation, the script compiler assembles data into a binary format that defines a state machine for use by the electrosurgical generator. Script compiler as shown in FIG. 9 in one embodiment is separate from the electrosurgical generator and is responsible for reading in text from the script source file and validating its contents.

When the memory module is inserted into the generator, the generator downloads a binary file that is stored in a ferromagnetic random access memory (FRAM) or microcontroller disposed within the module. The binary includes logic for implementing the above-described treatment algorithm. The generator includes firmware/software responsible for processing the binary to authentic the connected instrument and to execute the binary for performing the treatment algorithm. In this manner, the generator is configured to operate only with authenticated, compatible hand tools.

In one embodiment, instrument scripts or script database represent an instrument process for a specific or given instrument. The instrument scripts are stored on memory connected to or integrated with an instrument, the controller or a combination thereof. The event handler responds to specific events, such as a switch activation/de-activation, instrument positions or exceeding measurement thresholds. The operations engine based on the detected event if appropriate for a given event provides output to the connected instrument. In one embodiment, an event is a discrete change, as in a switch is asserted or de-asserted.

Script state is a block or set of script functions or operation conditions and script events or indicators. Script functions are configurable instructions for controlling the generator and/or the instruments. Script operators are logical and comparison operations performed during a script event evaluation. Script parameters are configuration data used by all states and events of a script and in one embodiment are declared in their own dedicated section of the script file. Script events are a discrete change in an electrosurgical generator measurement. When a Script Event occurs, for example, a sequence of script functions is executed.

In one embodiment, the controller has a specific or predetermined fixed instrument script for a specific input receptacle. As such, only this instrument script is used for the instrument connected to the particular input receptacle. The event handler receives and identifies instrument events or indicators, such as a switch activation/de-activation event or a measurement event (e.g., phase threshold exceeded). The operations engine formulates requests or operations to the RF amplifier to control RF output, output selection and/or selection of outputs. Other events or indicators detected include detecting hand and foot switches, jaw switches, phase over and phase under-after-over events, shorts and opens, instrument script states. Keywords in the scripts assist the operations engine to extract operational commands and data for instrument operation based on a detected event identified by the event handler.

The script in one embodiment controls the voltage and current output settings as well as sequences of voltage and current settings. Generally, a small blood vessel will fuse very rapidly while a large vessel may take several seconds. Applying a large amount of current to a small vessel may cause excess tissue damage, while using a small amount of current will take an unacceptably long time to perform the fusion function. In one embodiment to modify instrument performance the script can initially command a small amount of RF current, and if fusion endpoint is not reached in less than one second for example a high current is commanded to speed the fusion of a large vessel. Another script usage to modify instrument performance in one embodiment is to switch from one operation (fuse) to another operation (cut) and for example to reconfigure the instrument electrodes and ESG output which simplifies a multistep process such as fuse and cut. When the clinician starts the process the script will first setup the unit for the fusion, measure the tissue phase angle that indicates the fusion endpoint. RF power is delivered until the fusion endpoint is reached. The unit will then turn off RF power and indicate that fusion is complete. The unit then switches the electrodes to a cut configuration, sets the RF output for cut, and restarts the RF output. The cut operation is stopped by the clinician when the cut is completed.

In one embodiment, upon activation of a switch coupled to the instrument, the controller detects the switch closure, and authenticates the instrument or device, checks the instrument's expiration status, and/or initializes internal data structures representing the receptacle's instrument. A subsequent activation of the instrument switch initiates an event that causes the script to direct the generator to supply RF energy. The controller logs the usage to both the instrument and the generator. When the instrument is disconnected from the receptacle of the generator, the controller resets the information associated with the receptacle. The controller in one embodiment constantly monitors the generator for proper operation. Unrecoverable errors and faults are announced and further operation of the system is prevented. All faults are stored in the controller's memory and/or the instrument's memory.

Data from a specific procedure (e.g., from power-up to power-down) is stored on each instrument. The instrument additionally holds the data from a procedure, i.e., the number of instrument uses, the power setting and faults. Each instrument in one embodiment holds the information from all other instruments as well. Instrument memory includes some or all of the following parameters, but is not limited to these parameters: serial number of generator, time stamp, tissue assessment and endpoint setting for each instrument use, cut, fuse, power setting, duration of RF and endpoint (auto stop, fault, manual stop, etc.).

In accordance with various embodiments, the Script Engine controls RF activation through a Script Database driven state machine. The Script Database can be read into the Script Engine via the tool ports when a device is plugged in or via a diagnostic port. The Script Engine waits for an event to be recognized by a Script Event Handler, and then executes functions associated with the received and recognized event. In one embodiment, initially, after executing a sequence of functions that constitute a state's setup or a state's event actions, the Script Engine instructs the Event Handler to check for events and then waits for notification from the Event Handler that an event has occurred. As such, the Event Handler checks for any event or combination of events which would cause the script engine to transition from a present state to a new state.

The Script Engine in accordance with various embodiments performs run-time checks to ensure that the executing script cannot damage the generator. In one embodiment, a Script Database is a binary data block containing a tokenized encoding of a script file. A Script Database is loaded by an external task into one of two sections of FRAM or SRAM memory (a region for each of tool ports). Script Binary Database is a binary file generated from a Script File by the Script Compiler and executed by the Operations Engine to control the operation of the electrosurgical generator and/or the electrosurgical instrument.

As previously described and described throughout the application, the electrosurgical generator ultimately supplies RF energy to a connected electrosurgical instrument. The electrosurgical generator ensures that the supplied RF energy does not exceed specified parameters and detects faults or error conditions. In various embodiments, however, an electrosurgical instrument provides the commands or logic used to appropriately apply RF energy for a surgical procedure. An electrosurgical instrument includes memory having commands and parameters that dictate the operation of the instrument in conjunction with the electrosurgical generator. For example, in a simple case, the generator can supply the RF energy but the connected instrument decides how much energy is applied. The generator however does not allow the supply of RF energy to exceed a set threshold even if directed to by the connected instrument thereby providing a check or assurance against a faulty instrument command.

As described generally above and described in further detail below, various handheld electrosurgical instruments or instruments can be used in the electrosurgical systems described herein. For example, electrosurgical graspers, scissors, tweezers, probes, needles, and other instruments incorporating one, some, or all of the aspects discussed herein can provide various advantages in an electrosurgical system. Various electrosurgical instrument embodiments are discussed below. It is contemplated that one, some, or all of the features discussed generally below can be included in any of the embodiment of instrument discussed below. For example, it can be desirable that each of the instruments described below include a memory for interaction with the generator as previously described. However, in other embodiments, the instruments described below can be configured to interact with a standard bipolar power source without interaction of an instrument memory. Furthermore, although it is contemplated that certain aspects of these embodiments can be combined with certain aspects of other electrosurgical instruments within the scope of this application.

As discussed above with respect to FIG. 1, an electrosurgical instrument can include a memory. The memory can include a configuration device module. The configuration device module can store certain types of instrument data. For example the configuration device module can store operational parameters for the instrument, including software to be transferred to an electrosurgical unit upon successful electrical connection to the electrosurgical unit. These operational parameters can include data regarding various electrosurgical procedures to be performed by the instrument and corresponding energy level ranges and durations for these operations, data regarding electrode configuration of an instrument, and data regarding switching between electrodes to perform different electrosurgical procedures with the instrument. Advantageously, changes to instrument profiles and periodic instrument updates can be rapidly made without downtime to electrosurgical generators, as the data for instrument operation can reside in electrosurgical instrument itself, rather than the generator. Accordingly, updates can be made during instrument production.

The configuration device module can further store a data log comprising, for example, a record of information of each previous instrument use. For example, in some embodiments, the data log can contain timestamp data including an electrosurgical unit identifier, a log of electrosurgical procedures perform by the instrument, and a log of durations and energies applied to the instrument. In some embodiments, it can be desirable that use of a particular instrument is limited to a maximum usage period or number of procedures, especially where electrosurgical instrument has not been configured for sterilization and reuse. Accordingly, in some embodiments, the configuration device module can be configured to prevent operation of an instrument after a predetermined usage or number of procedures. In some embodiments, an instrument can comprise a mechanical lockout in addition to or in place of the data log, such as a breakaway single-use connector to reduce the possibility of unintended reuse.

The electrosurgical instrument in one embodiment has two separate electrodes capable of carrying RF energy (375 VA, 150V, 5 A at 350 kHz+/−5 kHz). The maximum output RF voltage is 150 Vrms, +/−7.5 Vrms. The maximum output RF current is 5 Arms, +/−0.25 Arms. The maximum output RF power is 375 VA, +/−18.75 VA.

In accordance with various embodiments, an electrosurgical instrument 20 is provided. The instrument 20 includes an actuator coupled to a rotatable shaft relative to the actuator. The elongate shaft has a proximal end and a distal end defining a central longitudinal axis therebetween. At the distal end of the shaft are jaws and at the proximal end is the actuator. In one embodiment, the actuator is a pistol-grip like handle. The shaft and jaws, in one embodiment, are sized and shaped to fit through a 5 mm diameter trocar cannula or access port.

The actuator includes a movable handle and a stationary handle or housing with the movable handle coupled and movable relative to the stationary housing. In accordance with various embodiments, the movable handle is slidably and pivotally coupled to the stationary housing. In operation, the movable handle is manipulated by a user, e.g., a surgeon to actuate the jaws, for example, selectively opening and closing the jaws. In various embodiments, the instruments comprise an advanceable cutting blade that can be coupled to a blade actuator such as a blade trigger of the actuator. A blade actuation mechanism can operatively couple the blade trigger to the cutting blade.

Attached to the distal end of the elongate shaft are jaws that comprise a first jaw and a second jaw. In one embodiment, a jaw pivot pin pivotally couples the first and second jaws and allows the first jaw to be movable and pivot relative to the second jaw. In various embodiments, one jaw is fixed with respect to the elongate shaft such that the opposing jaw pivots with respect to the fixed jaw between an open and a closed position. In other embodiments, both jaws can be pivotally coupled to the elongate shaft such that both jaws can pivot with respect to each other.

Attached to the first jaw is a conductive pad. In one embodiment, the isolated wire is routed to electrically couple the conductive pad on the first jaw to the wiring harness in the actuator. The isolated wire extends from the distal end of the protective sleeve which is housed at the proximal end of the second jaw and extends into the first jaw. The first jaw can have a slot positioned to receive the isolated wire. The isolated wire then extends through a hole in the first jaw and drops into a slot in a nonconductive portion. The isolated wire then extends to the distal end of the nonconductive portion and drops through to the conductive pad.

Turning now to some of the operational aspects of the electrosurgical instruments described herein, once a vessel or tissue bundle has been identified for sealing, the first and second jaws are placed around the tissue. The movable handle is squeezed moving the movable handle proximally with respect to the stationary housing. As the movable handle moves proximally it pushes a pull block. The pull block engages with a pull tube causing the pull tube to move proximally. Proximal movement of the pull tube pivots the first jaw towards the second jaw effectively clamping the tissue. The force applied to the tissue by the first jaw is translated through the pull tube and pull block to the movable handle. Once the preloaded force has been overcome, the movable handle will begin to move a sliding pin distally. When the preload on the spring has been overcome, the movable handle pivot point shifts from the sliding pin to the rear portion of the pull block where it contacts the movable handle. The sliding pin can advance distally because the preloaded force on the trigger spring has been overcome.

The continued manipulation of the movable handle pivots the movable handle to a location where the movable handle engages with a latch mechanism that maintains the movable handle in the engaged position and prevents the handle from returning to an opened position. From the engaged position, sealing radio frequency energy is applied to the tissue by depressing the power activation button. Once the tissue has been fused, the movable handle can be reopened by continuing proximal advancement to a position that allows the latch mechanism to disengage.

The force regulation mechanism reduces the risk that an extremely large amount of force is applied to the tissue. If too much force is applied to a vessel or tissue bundle, potential damage could occur. Thus, if a very small vessel or thin tissue bundle is clamped within the jaw, the instrument applies the minimum amount of force required to obtain a good tissue fuse. The same is true with a very large vessel or tissue bundle.

Once the tissue has been fused, the user can actuate the blade trigger. When the blade trigger is moved proximally, the blade lever pivots, forcing a push bar and a cutting blade to move distally. The cutting blade advances forward and divides the fused portion of the tissue. When the user releases the blade trigger, the blade spring resets the cutting blade to its original position. When the blade trigger has been returned to its original or initial position the user can continue to squeeze the movable handle to open the upper jaw. Continued proximal movement of the movable handle will disengage the latch mechanism to a position where the movable handle can be released.

The dimensions of the sealing surface are such that it is appropriately proportioned with regards to the optimal pressure applied to the tissue between the jaws for the potential force the device mechanism can create. Its surface area is also electrically significant with regards to the surface area contacting the tissue. This proportion of the surface area and the thickness of the tissue have been optimized with respect to its relationship to the electrical relative properties of the tissue. The jaws are arranged to maintain electrically significant spacing between the jaws in relation to the thickness of tissue held between the jaws.

As discussed above with respect to the electrosurgical system, in some embodiments, the electrosurgical fusion instrument can be used in a system which monitors various operational parameters and determines a radiofrequency endpoint based on phase angle.

With reference to FIGS. 21-40, in accordance with various embodiments, an electrosurgical fusion instrument or device is provided that in accordance with various embodiments is removably connectable to an electrosurgical generator. In the illustrated embodiment, the instrument includes an actuator 224 coupled to a rotatable shaft 226 relative to the actuator. The elongate shaft 226 has a proximal end and a distal end defining a central longitudinal axis therebetween. At the distal end of the shaft 226 are jaws 222 and at the proximal end is the actuator. In one embodiment, the actuator is a pistol-grip like handle. The shaft 226 and jaws 222, in one embodiment, are sized and shaped to fit through a 5 mm diameter trocar cannula or access port.

The actuator 224 includes a movable handle 223 and a stationary handle or housing 28 with the movable handle 223 coupled and movable relative to the stationary housing. In accordance with various embodiments, the movable handle 223 is slidably and pivotally coupled to the stationary housing. In operation, the movable handle 223 is manipulated by a user, e.g., a surgeon to actuate the jaws, for example, selectively opening and closing the jaws.

In accordance with various embodiments, the actuator 224 includes a force regulation mechanism that is configured such that in a closed configuration, the jaws 222 delivers a gripping force between a predetermined minimum force and a predetermined maximum force.

As part of the force regulation mechanism, the movable handle 223 is coupled to the stationary handle at two sliding pivot locations to form the force regulation mechanism. The movable handle has a first end including a gripping surface formed thereon and a second end 258 opposite the first end. The movable handle is coupled to a pin 256 adjacent the second end. In some embodiments, the movable handle can be integrally formed with a protrusion extending therefrom defining a pin surface. In other embodiments, a pin can be press-fit into an aperture in the movable handle. The pin can be contained within slots in the stationary housing, such as a corresponding slot formed in a right and/or left handle frames of the stationary housing. In some embodiments, the slots can be configured to define a desired actuation handle path, such as a curved or angled path, as the actuation handle is moved from the first position corresponding to open jaws to a second position corresponding to closed jaws.

The force regulation mechanism includes a biasing member such as a tension spring 257 that biases the pin in a proximal direction. In operation, as a predetermined force is exerted on by movement of the movable handle 223, a biasing force exerted by the spring is overcome, and the second end of the movable handle can translate generally distally, guided by the pin in the slots.

In accordance with various embodiments, the movable handle is slidably and pivotably coupled to the stationary housing 228 at a location between the first and second ends of the actuation handle. An actuation member such as a pull block 251 is coupled to the actuation handle. When the movable handle is moved proximally, the pull block also moves proximally and longitudinally, closing the jaws 222 thereby clamping any tissue between the jaws. The pull block 251 in accordance with various embodiments is rectangular having open top and bottom faces and a closed proximal end. The movable handle extends through the top and bottom faces of the pull block. An edge of the movable handle bears on the proximal end of the pull block such that movement of the movable handle relative to the stationary housing moves the pull block longitudinally. A distal end of the pull block in one embodiment is coupled to an actuation shaft such as a pull tube, bar, or rod, which can extend longitudinally along the elongate shaft 226. Thus, in operation, movement of the movable handle from the first position to the second position translates the pull block 251 longitudinally within the stationary housing, which correspondingly translates the pull tube generally linearly along the longitudinal axis with respect to the elongate shaft 226. Movement of this pull tube can control relative movement of the jaws 222.

In accordance with various embodiments, the actuator 224 includes a latch mechanism to maintain the movable handle 223 in a second position with respect to the stationary housing 228. In the illustrated embodiment, the movable handle comprises a latch arm 265 which engages a matching latch 267 contained within stationary handle for holding the movable handle at a second or closed position.

In various embodiments, the instrument comprises an advanceable cutting blade 271 that can be coupled to a blade actuator such as a blade trigger 225 of the actuator 224. A blade actuation mechanism can operatively couple the blade trigger to the cutting blade. In one embodiment, the blade actuation mechanism comprises a pivoting blade advancement link that transfers and reverses the proximal motion of the blade trigger 225 to a blade actuation shaft assembly, such as a push bar, coupled to the cutting blade. In operation, a user can move the blade trigger 225 proximally to advance the cutting blade 271 from a retracted position to an extended position. The blade actuation mechanism can include a biasing member such as a blade return spring 263 to bias the cutting blade into the retracted position.

The cutting component can be selectively moved between a proximal location and a distal location to cut tissue compressed between the jaws of the jaw assembly. In various embodiments, the cutting blade 271 can be a sharp blade, hook, knife, or other cutting element that is sized and configured to cut tissue between the jaws. In some embodiments, the cutting blade includes a first sharpened edge and a second sharpened edge on each of a proximal edge and a distal edge of the cutting blade to allow cutting of tissue when the cutting blade is moved either proximally or distally along a slot or channel in the jaws.

The actuator also comprises a wire harness that includes insulated individual electrical wires or leads contained within a single sheath. The wire harness can exit the stationary housing at a lower surface thereof and form part of the cabled connection. The wires within the harness can provide electrical communication between the instrument and the electrosurgical generator and/or accessories thereof.

In accordance with various embodiments, the actuator includes one or more leads attached to rotational coupling clips configured to allow infinite rotation of the shaft. In various embodiments, a switch is connected to a user manipulated activation button 229 and is activated when the activation button is depressed. In one aspect, once activated, the switch completes a circuit by electrically coupling at least two leads together. As such, an electrical path is then established from an electrosurgical generator to the actuator to supply RF energy to the leads attached to the rotational coupling clips.

In one embodiment, the actuator includes a rotation shaft assembly including a rotation knob 227 which is disposed on an outer cover tube of the elongate shaft 226. The rotation knob allows a surgeon to rotate the shaft of the device while gripping the actuator 224.

In accordance with various embodiments, the elongate shaft 226 comprises an actuation tube coupling the jaws 222 with the actuator and a blade actuation shaft assembly coupling the actuator with a cutting blade 271. In various embodiments, the blade actuation shaft assembly comprises a two-piece shaft having a proximal portion and a distal portion. The proximal portion of the blade shaft assembly terminates at a proximal end at an interface node. The interface node comprises a generally spherical protrusion portion which is adapted to engage the blade advancing lever. In other embodiments, the interface node can comprise other geometries such as cubic or rectangular prismatic protrusions. The proximal portion of the blade shaft is operatively coupled to the distal portion of the blade shaft assembly. The distal portion of the blade shaft can comprise a mount at its distal end for attachment of the cutting blade. In certain embodiments, both the proximal and distal portions of the blade shaft are at least partially positioned within a generally tubular section of the actuation tube.

In various embodiments, the actuation tube is housed within an outer cover tube. While the actuation tube is illustrated as a generally tubular member that can be nested within the outer cover tube, and that can have a blade actuation shaft nested within it, in other embodiments, a non-tubular actuation member can be used, for example, a shaft, a rigid band, or a link, which, in certain embodiments can be positioned generally parallel to the blade actuation shaft within the outer cover tube.

In accordance with various embodiments, attached to the distal end of the outer cover tube is a rotational shaft assembly comprising of two mating hubs and a conductive sleeve. The hubs snap together, engaging with the outer cover tube. In other embodiments, the hubs can be of a monolithic construction and configured to interface with mating features on the outer cover tube. The conductive sleeve can be attached to the proximal portion of the assembled hubs after they are attached to the outer cover tube. When the conductive sleeve is attached to the rear of the assembled hubs, the sleeve traps the exposed end of an isolated wire. In the illustrated embodiment, the isolated wire extends from its entrapment point under the conductive sleeve through a slot in the actuation tube and then inside a protective sleeve. The protective sleeve and isolated wire extend distally inside the actuation tube, towards the jaws. In other embodiments, the isolated wire can be formed integrally with a protective sheath and no separate protective sleeve is present in the actuation tube.

Attached to the distal end of the elongate shaft are jaws 222 that include a first jaw 270 and a second jaw 280. In one embodiment, a jaw pivot pin pivotally couples the first and second jaws and allows the first jaw to be movable and pivot relative to the second jaw. In various embodiments, one jaw is fixed with respect to the elongate shaft such that the opposing jaw pivots with respect to the fixed jaw between an open and a closed position. In other embodiments, both jaws can be pivotally coupled to the elongate shaft such that both jaws can pivot with respect to each other.

Attached to the first jaw is a conductive pad 272. In one embodiment, the isolated wire 273 is routed to electrically couple the conductive pad on the first jaw to the wiring harness in the actuator. The isolated wire extends from the distal end of the protective sleeve which is housed at the proximal end of the second jaw and extends into the first jaw. The first jaw can have a slot positioned to receive the isolated wire. The isolated wire then extends through a hole in the first jaw and drops into a slot in a nonconductive portion. The isolated wire then extends to the distal end of the nonconductive portion and drops through to the conductive pad.

In some embodiments, electrode geometry on the conductive pads of the jaw assembly ensures that the sealing area completely encloses the distal portion of the blade cutting path. In embodiment, the conductive pad 272 and the second jaw 280 are curved at the edges to maintain a distinctive sealing surface in contact with tissue between the jaws, reduced unwanted concentrated current density and/or to assist in cutting of tissue between the jaws. In some embodiments, for some surgical procedures the outer shape of the jaws can be curved such that the distal ends of the jaws are offset with respect to the longitudinal axis from the proximal ends of the jaws to improve visibility for a user such as a surgeon.

In accordance with various embodiments, the dimensions of the jaw surfaces are such that it is appropriately proportioned with regards to the optimal pressure applied to the tissue between the jaws for the potential force the force mechanism can create. Its surface area is also electrically significant with regards to the surface area contacting the tissue. This proportion of the surface area and the thickness of the tissue have been optimized with respect to its relationship to the electrical relative properties of the tissue.

The jaws are arranged to maintain electrically significant spacing between the jaws in relation to the thickness of tissue held between the jaws. In one embodiment, at least one jaw includes a conductive post 281 extending in a direction traverse to the longitudinal direction of the jaw. The post in various embodiments protrudes through an inner surface of the second jaw or lower jaw assembly and towards an inner surface or a conductive pad of the first jaw.

The conductive posts in one embodiment are made from a conductive material such as stainless steel. The conductive post in one embodiment being made from a stainless steel provides high compressive and/or column strength. As such, the conductive post can endure more operational wear and tear and can be dimensionally small relative to the dimensions of the jaw with a reduced concern of breakage or dislodgement or occupying excessive space on the jaw. In one embodiment the conductive posts are made of a material that is the same material as the conductive pad on the first and/or second jaws.

In accordance with various embodiments, multiple posts provided and support an inner edge of the conductive surface of the jaw that is adjacent to a blade channel within the jaw. In accordance with various embodiments, the posts also provide additional surface texture to aid with capturing and griping the tissue that is captured within the jaws of the device. The conductive posts however do not have and edge or an otherwise atraumatic surface to pierce, puncture or otherwise protrude through tissue grasped between the jaws.

The conductive post in one embodiment supports an inner edge of a conductive surface that is adjacent to the blade channel. The posts are biased to be at the edge of the blade channel. When the jaws are closed and RF energy is supplied, the conductive post is the same electrical potential as the conductive surface. The configuration of the conductive post relative to the conductive surface and the conductive post being the same electrical potential as the upper conductive surface provide in one embodiment a tissue treating surface that is uninterrupted along the jaw. In one embodiment, the configuration and electrical potential provide the application of RF energy allows heating and sealing around the conductive post further enhancing the seal quality or tissue treatment of the tissue between the jaws.

Additionally, to improve seal quality and reduce the potential for higher current density at the edges of the upper and lower conductive surfaces, the upper and lower conductive surfaces in one embodiment have a lead-in angle 274 and/or radius 275, 283 configuration. In addition to addressing current density the radius also presents an atraumatic radii edge to the vessel adjacent to the area affected by RF energy application to help prevent cutting at the edge of the surface of the jaws.

The conductive posts in one embodiment are disposed along the jaw and each at a differing height relative to the others such that they are not on the same plane. In one embodiment, the conductive posts as such provide that the first or distal most conductive post to contact tissue first then one or more intermediate conductive posts and finally a proximal most conductive post. In one embodiment, the distal most post is 0.005″, the intermediate is 0.004″ and the proximal most post is 0.003″. Such a staggered arrangement ensures the jaws or inner surfaces remain relatively parallel relative to the tissue and each other by compensating for the deflection of the first and/or second jaws when the force is applied. The height difference of the posts relative to the jaw in one embodiment can lift or raise portions of the tissue near or adjacent the blade channel and thereby aids with the gripping of the tissue as it is being cut and thereby provides a smoother cut and eases the cutting operation.

In one embodiment, the first jaw or upper jaw assembly comprises a stamped sheet metal conductive pad 272 that is held at a distance from the machined upper metal jaw 275 by a high service non-conductive temperature plastic material 276. The stamped sheet metal, non-conductive plastic material and machined upper metal jaw are placed into a mold which is subsequently filled with a thermoplastic. The result of the process is an over molded upper machined or MIM (metal injection molded) jaw, stamped conductive pad and high temperature plastic that are fixed or held together by the thermoplastic over-molding to make the first or upper jaw. In one embodiment, the upper jaw includes an injection molded component in place of the high service temperature non-conductive plastic material.

In one embodiment, the second jaw or lower jaw assembly comprises a machined or MIM jaw and machined or MIM electrically conductive posts 281. In one embodiment, the posts and jaw are made of the same material. The jaw and posts are placed into a mold which is subsequently filled with a thermoplastic. The result of the process is an over-molded lower jaw and conductive posts that are fixed or held together by the thermoplastic over-molding to make the lower jaw. By the posts extending from the lower jaw assembly and through an inner surface of the jaw, the strength and/or stability of the conductive posts are enhanced relative to the jaws and/or tissue. As such, in one embodiment, the post has a height that is at least twice the thickness of the conductive pad. In one embodiment, the post has a bottom portion that extends into about half the thickness or depth of the first and/or second jaw. Upon assembly a jaw gap is set in a fixture and laser welded and in one embodiment this is facilitated by a slotted hole in the lower jaw and a dowel.

Referring to FIGS. 38-40, in one embodiment, a return path connection 285 is provided to connect the conductive posts to the generator. In such an embodiment, the conductive posts can provide additional feedback information such as applied voltage, current, power and phase, or tissue properties. In one embodiment, the return path connection provides an indicator or cutoff switch such that if the cutting blade enters the jaw a circuit is developed or a deliberate short is triggered to terminate RF energy and thereby ensure that RF energy is not being supplied while the blade is being actuated. In one embodiment, a thermistor or a temperature sensor 286 is disposed under or inline with the conductive post and connected back with a wire or return connection through the lower jaw to monitor the temperature, e.g., via the change in the thermistor caused by the temperature change. In one embodiment the electrosurgical generator can then account for the temperature of the tissue and the jaws that can effect fusing of the tissue and/or the application of the RF energy. In one embodiment, the second or lower jaw includes plates or a capacitive arrangement or sensor 287 and in one embodiment the electrosurgical generator can then measures the capacitance between a bottom surface of the conductive post and a portion of the jaw to account for instrument or tissue capacitance that can effect fusing of the tissue and/or the application of RF energy.

In accordance with various embodiments, an electrosurgical system can include an electrosurgical generator and an electrosurgical instrument. The electrosurgical instrument is used in laparoscopic procedures where the ligation and division of vessels and tissue bundles are desired. The electrosurgical instrument fuses vessels by delivering radio frequency (RF) energy to tissue captured between the jaws of the device and divides sealed tissue with a user-actuated blade. The generator can provide an electrosurgery endpoint by determining the phase end point of a tissue to be treated. The electrosurgical system can include more than one electrosurgical instrument for different electrosurgical operations and can include a variety of user interface features and audio/visual performance indicators. The electrosurgical system can also power conventional bipolar electrosurgical instruments and direct current surgical appliances.

Turning now to some of the operational aspects of the electrosurgical instrument or instrument described herein in accordance with various embodiments, once a vessel or tissue bundle has been identified for fusing, the first and second jaws are placed around the tissue. The movable handle 223 is squeezed moving the movable handle proximally with respect to the stationary housing 228. As the movable handle moves proximally it pushes the pull block. The pull block engages with the pull tube causing the pull tube to move proximally. Proximal movement of the pull tube pivots the first jaw towards the second jaw effectively clamping the tissue. In FIGS. 27-28, the actuator 224 is shown in a first or initial position in which the jaws 222 are in an open position and in one embodiment the first and second jaws opening defines about a 30 degree angle.

The continued manipulation of the movable handle pivots the movable handle to a location where the movable handle engages with the latch mechanism that maintains the movable handle in the engaged position and prevents the handle from returning to an opened position. From the engaged position, radio frequency energy is applied to the tissue by depressing the activation button. Once the tissue has been fused, the movable handle is reopened by continuing proximal advancement to a position that allows the latch mechanism to disengage. In FIGS. 30-31, the actuator 224 is shown in an engaged position in which the jaws 222 are closed and the movable handle is latched.

Alternatively or additionally, the user can actuate the blade trigger 225. When the blade trigger is moved proximally, the blade lever pivots, forcing the push bar and the cutting blade to move distally. The cutting blade advances forward and divides the sealed portion of the tissue. When the user releases the blade trigger, the blade spring resets the cutting blade to its original position. When the blade trigger has been returned to its original or initial position the user can continue to squeeze the movable handle to open the upper jaw. In FIGS. 32-33, the actuator 224 is shown in a cutting position in which the jaws 222 are in a closed position and the blade trigger has been depressed advancing the cutting blade to its distal most position. Continued proximal movement of the movable handle will disengage the latch mechanism to a position where the movable handle can be released. In FIG. 29, an intermediate position is shown in which the jaws are in a closed position and the movable handle is not latched. In one embodiment, the blade trigger may be activated to cut tissue between the jaws and/or the fuse button or switch may be activated to fuse tissue between the jaws.

Further examples of the electrosurgical unit, instruments and connections there between and operations and/or functionalities thereof are described in U.S. patent application Ser. No. 12/416,668, filed Apr. 1, 2009, entitled “Electrosurgical System”; Ser. No. 12/416,751, filed Apr. 1, 2009, entitled “Electrosurgical System”; Ser. No. 12/416,695, filed Apr. 1, 2009, entitled “Electrosurgical System”; Ser. No. 12/416,765, filed Apr. 1, 2009, entitled “Electrosurgical System”; and Ser. No. 12/416,128, filed Mar. 31, 2009, entitled “Electrosurgical System”; the entire disclosures of which are hereby incorporated by reference as if set in full herein.

The above description is provided to enable any person skilled in the art to make and use the surgical instruments and perform the methods described herein and sets forth the best modes contemplated by the inventors of carrying out their inventions. Various modifications, however, will remain apparent to those skilled in the art. It is contemplated that these modifications are within the scope of the present disclosure. Different embodiments or aspects of such embodiments may be shown in various figures and described throughout the specification. However, it should be noted that although shown or described separately each embodiment and aspects thereof may be combined with one or more of the other embodiments and aspects thereof unless expressly stated otherwise. It is merely for easing readability of the specification that each combination is not expressly set forth.

Although the present invention has been described in certain specific aspects, many additional modifications and variations would be apparent to those skilled in the art. It is therefore to be understood that the present invention may be practiced otherwise than specifically described, including various changes in the size, shape and materials, without departing from the scope and spirit of the present invention. Thus, embodiments of the present invention should be considered in all respects as illustrative and not restrictive.

Claims

1. An electrosurgical system comprising: an electrosurgical instrument arranged to grasp and fuse tissue using radio frequency (RF) energy; andan electrosurgical generator connectable to the electrosurgical instrument and configured to supply the RF energy through the electrosurgical instrument, the generator comprising:an RF amplifier arranged to supply the RF energy through the electrosurgical instrument in which voltage of the supplied RF energy is applied in a ramping fashion and subsequently held constant, wherein the voltage of the supplied RF energy is held constant at a predetermined voltage,a controller arranged to monitor a phase angle of the supplied RF energy, the controller is configured to signal the RF amplifier to terminate the supply of the RF energy when the monitored phase angle is less than a predefined phase value, wherein the predefined phase value is less than zero degrees.
2. The system of claim 1 wherein the voltage of the supplied RF energy applied in the ramping fashion starts from a voltage being 25 percent of a predefined voltage setting to a voltage being 80 percent of the predefined voltage setting.
3. The system of claim 1 wherein the electrosurgical generator further comprises: a RF sense circuitry arranged to receive a supplied RF waveform from the supplied RF energy through the electrosurgical instrument; and a synchronous detector arranged to calculate real and imaginary voltage and current components of the supplied RF waveform.
4. The system of 1 wherein the electrosurgical instrument comprises: a first jaw having a first electrode;a second jaw coupled to the first jaw and having a second electrode facing the first electrode, the first and second electrodes arranged to conduct the supplied RF energy between the first and second electrodes;an elongate shaft having a proximal end and a distal end and a longitudinal axis extending from the proximal end to the distal end, the first and second jaws being pivotably coupled to the distal end of the elongate shaft; anda conductive post extending from the second jaw towards the first jaw, the conductive post being stationary and made of a conductive material.
5. The system of claim 4 wherein the electrosurgical instrument further comprises a blade movable from a proximal position to a distal position through a channel in the second jaw.
6. The system of claim 5 wherein the conductive post is positioned next to the channel in the second jaw.
7. The system of claim 6 wherein the electrosurgical generator is arranged to supply the RF energy only to the first and second electrodes and not the conductive post and the blade.

CROSS-REFERENCE TO RELATED APPLICATIONS

This is application is a continuation of U.S. patent application Ser. No. 14/848,116, filed Sep. 8, 2015, now U.S. Pat. No. 10,149,713 which is a continuation of International Application No. PCT/US2015/031452, filed May 18, 2015, which claims the benefit of U.S. Provisional Application No. 61/994,192, filed on May 16, 2014; U.S. Provisional Application No. 61/994,185, filed on May 16, 2014; U.S. Provisional Application No. 61/994,415, filed on May 16, 2014; and U.S. Provisional Application No. 61/994,215, filed May 16, 2014, the entire disclosures of which are incorporated by reference as if set forth in full herein.

US Referenced Citations (1162)

Number	Name	Date	Kind
371664	Brannan et al.	Oct 1887	A
702472	Pignolet	Jun 1902	A
728883	Downes	May 1903	A
1586645	Bierman	Jun 1926	A
1935289	Evans	Apr 1933	A
2002594	Wappler et al.	May 1935	A
2031682	Wappler et al.	Feb 1936	A
2113246	Wappler	Apr 1938	A
2176479	Willis	Oct 1939	A
2305156	Grubel	Apr 1941	A
2632661	Cristofv	Mar 1953	A
2827056	Degelman	Mar 1958	A
3085566	Tolles	Apr 1963	A
3459187	Pallotta	Aug 1969	A
3494363	Jackson	Feb 1970	A
3588710	Masters	Jun 1971	A
3651811	Hildebrandt et al.	Mar 1972	A
3685518	Beuerle et al.	Aug 1972	A
3780416	Rider	Dec 1973	A
3826263	Cage	Jul 1974	A
3911766	Fridolph	Oct 1975	A
3920021	Hiltebrandt	Nov 1975	A
3938527	Rioux	Feb 1976	A
3963030	Newton	Jun 1976	A
3970088	Morrison	Jul 1976	A
3980085	Ikuno	Sep 1976	A
3987795	Morrison	Oct 1976	A
4030501	Archibald	Jun 1977	A
4041952	Morrison, Jr. et al.	Aug 1977	A
4043342	Morrison	Aug 1977	A
4060088	Morrison, Jr. et al.	Nov 1977	A
4074718	Morrison, Jr.	Feb 1978	A
4089336	Cage	Jun 1978	A
4092986	Schneiderman	Jun 1978	A
4094320	Newton et al.	Jun 1978	A
4114623	Meinke	Sep 1978	A
4126137	Archibald	Nov 1978	A
4154240	Ikuno	May 1979	A
4171700	Farin	Oct 1979	A
4181131	Ogui	Jan 1980	A
4188927	Harris	Feb 1980	A
4196734	Harris	Apr 1980	A
4198957	Cage et al.	Apr 1980	A
4198960	Utsugi	Apr 1980	A
4200104	Harris	Apr 1980	A
4231372	Newton	Nov 1980	A
4237887	Gonser	Dec 1980	A
4244371	Farin	Jan 1981	A
4325374	Komiya	Apr 1982	A
4331149	Gonser	May 1982	A
4338940	Ikuno	Jul 1982	A
4352156	Gyugyi	Sep 1982	A
4370980	Lottick	Feb 1983	A
4416276	Newton	Nov 1983	A
4416277	Newton et al.	Nov 1983	A
4427014	Bel	Jan 1984	A
4429694	McGreevy	Feb 1984	A
4463759	Garito et al.	Aug 1984	A
4487489	Takamatsu	Dec 1984	A
4514619	Kugelman	Apr 1985	A
4522206	Whipple et al.	Jun 1985	A
4552143	Lottick	Nov 1985	A
4569131	Faulk et al.	Feb 1986	A
4569345	Manes et al.	Feb 1986	A
4590934	Malis et al.	May 1986	A
4599553	Brennen et al.	Jul 1986	A
4630218	Hurley	Dec 1986	A
4632109	Paterson	Dec 1986	A
4644950	Valli	Feb 1987	A
4651280	Chang et al.	Mar 1987	A
4655216	Tischer	Apr 1987	A
4657018	Hakky	Apr 1987	A
4658815	Farin et al.	Apr 1987	A
4658819	Harris et al.	Apr 1987	A
4658820	Klicek	Apr 1987	A
4674498	Stasz	Jun 1987	A
4685459	Koch et al.	Aug 1987	A
4699146	Sieverding	Oct 1987	A
4712545	Honkanen	Dec 1987	A
4716897	Noguchi et al.	Jan 1988	A
4727874	Bowers	Mar 1988	A
4739759	Rexroth et al.	Apr 1988	A
4741334	Irnich	May 1988	A
4752864	Clappier	Jun 1988	A
4754757	Feucht	Jul 1988	A
4788977	Farin et al.	Dec 1988	A
4802476	Noerenberg et al.	Feb 1989	A
4818954	Flachenecker	Apr 1989	A
4827927	Newton	May 1989	A
4848335	Manes	Jul 1989	A
4850353	Stasz et al.	Jul 1989	A
4860745	Farin et al.	Aug 1989	A
4862889	Feucht	Sep 1989	A
4862890	Stasz et al.	Sep 1989	A
4872456	Hasson	Oct 1989	A
4887612	Esser et al.	Dec 1989	A
4889722	Sheffield et al.	Dec 1989	A
4903696	Stasz et al.	Feb 1990	A
4905691	Rydell	Mar 1990	A
4922903	Welch et al.	May 1990	A
4936281	Stasz	Jun 1990	A
4937254	Sheffield et al.	Jun 1990	A
4938761	Ensslin	Jul 1990	A
4942313	Kinzel	Jul 1990	A
4958539	Stasz et al.	Sep 1990	A
4969885	Farin	Nov 1990	A
4976711	Parins et al.	Dec 1990	A
5007908	Rydell	Apr 1991	A
5013312	Parins et al.	May 1991	A
5015227	Broadwin et al.	May 1991	A
5016521	Haka	May 1991	A
5026370	Lottick	Jun 1991	A
5026371	Rydell et al.	Jun 1991	A
5035696	Rydell	Jul 1991	A
5038109	Goble et al.	Aug 1991	A
5047026	Rydell	Sep 1991	A
5047027	Rydell	Sep 1991	A
5052402	Bencini et al.	Oct 1991	A
5057107	Parins et al.	Oct 1991	A
5061269	Muller	Oct 1991	A
5062031	Flachenecker et al.	Oct 1991	A
5071419	Rydell et al.	Dec 1991	A
5078717	Parins et al.	Jan 1992	A
5083565	Parins	Jan 1992	A
5085659	Rydell	Feb 1992	A
5087257	Farin et al.	Feb 1992	A
5098431	Rydell	Mar 1992	A
5116332	Lottick	May 1992	A
5122137	Lennox	Jun 1992	A
5125928	Parins et al.	Jun 1992	A
5127412	Cosmetto et al.	Jul 1992	A
5151102	Kamiyama et al.	Sep 1992	A
5158561	Rydell et al.	Oct 1992	A
5160343	Brancel et al.	Nov 1992	A
5167658	Ensslin	Dec 1992	A
5171255	Rydell	Dec 1992	A
5171311	Rydell	Dec 1992	A
5190517	Klicek et al.	Mar 1993	A
5190541	Abele et al.	Mar 1993	A
5192280	Parins	Mar 1993	A
5197963	Parins	Mar 1993	A
5197964	Parins	Mar 1993	A
5201732	Parins et al.	Apr 1993	A
5217457	Delahuerga et al.	Jun 1993	A
5217458	Parins	Jun 1993	A
5234427	Ohtomo et al.	Aug 1993	A
5244462	Delahuerga et al.	Sep 1993	A
5246440	Van Noord	Sep 1993	A
5250047	Rydell	Oct 1993	A
5250056	Hasson	Oct 1993	A
5254126	Filipi et al.	Oct 1993	A
5256149	Banik et al.	Oct 1993	A
5258006	Rydell et al.	Nov 1993	A
5267997	Farin et al.	Dec 1993	A
5269780	Roos	Dec 1993	A
5273524	Fox et al.	Dec 1993	A
5281216	Klicek	Jan 1994	A
5282799	Rydell	Feb 1994	A
5286255	Weber	Feb 1994	A
5290286	Parins	Mar 1994	A
5300070	Gentelia et al.	Apr 1994	A
5304190	Reckelhoff et al.	Apr 1994	A
5312329	Beaty et al.	May 1994	A
5314424	Nicholas	May 1994	A
5318563	Malis et al.	Jun 1994	A
5322055	Davison et al.	Jun 1994	A
5324289	Eggers	Jun 1994	A
5330471	Eggers	Jul 1994	A
5334183	Wuchinich	Aug 1994	A
5338317	Hasson et al.	Aug 1994	A
5341807	Nardella	Aug 1994	A
5341815	Cotone et al.	Aug 1994	A
5342359	Rydell	Aug 1994	A
5342381	Tidemand	Aug 1994	A
5352222	Rydell	Oct 1994	A
5352223	McBrayer et al.	Oct 1994	A
5354313	Boebel	Oct 1994	A
5356408	Rydell	Oct 1994	A
5370645	Klicek et al.	Dec 1994	A
5372124	Takayama et al.	Dec 1994	A
5372596	Klicek et al.	Dec 1994	A
5374277	Hassler	Dec 1994	A
5382247	Cimino et al.	Jan 1995	A
5383880	Hovven	Jan 1995	A
5383922	Zipes et al.	Jan 1995	A
5387196	Green et al.	Feb 1995	A
5387197	Smith et al.	Feb 1995	A
5389104	Hahnen et al.	Feb 1995	A
5389849	Asano et al.	Feb 1995	A
5391166	Eggers	Feb 1995	A
5392917	Alpern et al.	Feb 1995	A
5400267	Denen	Mar 1995	A
5403312	Yates et al.	Apr 1995	A
5403342	Tovey et al.	Apr 1995	A
5405344	Willaimson et al.	Apr 1995	A
5409498	Braddock et al.	Apr 1995	A
5417687	Nardella et al.	May 1995	A
5422567	Matsunaga	Jun 1995	A
5423808	Edwards et al.	Jun 1995	A
5423810	Goble et al.	Jun 1995	A
5431638	Hennig et al.	Jul 1995	A
5431649	Mulier et al.	Jul 1995	A
5431674	Basile et al.	Jul 1995	A
5432459	Thompson et al.	Jul 1995	A
5436566	Thompson et al.	Jul 1995	A
5437664	Cohen et al.	Aug 1995	A
5438302	Goble	Aug 1995	A
5443463	Stern et al.	Aug 1995	A
5445142	Hassler, Jr.	Aug 1995	A
5445638	Rydell et al.	Aug 1995	A
5447513	Davison et al.	Sep 1995	A
5449355	Rhum et al.	Sep 1995	A
5456684	Schmidt et al.	Oct 1995	A
5458598	Feinberg et al.	Oct 1995	A
5460182	Goodman et al.	Oct 1995	A
5462546	Rydell	Oct 1995	A
5464144	Guy et al.	Nov 1995	A
5472439	Hurd	Dec 1995	A
5472442	Klicek	Dec 1995	A
5472443	Cordis et al.	Dec 1995	A
5472451	Freitas et al.	Dec 1995	A
5474057	Makower et al.	Dec 1995	A
5476479	Green et al.	Dec 1995	A
5478351	Meade et al.	Dec 1995	A
5484400	Edwards et al.	Jan 1996	A
5486185	Freitas et al.	Jan 1996	A
5496312	Klicek	Mar 1996	A
5496317	Goble et al.	Mar 1996	A
5499992	Meade et al.	Mar 1996	A
5499998	Meade et al.	Mar 1996	A
5503320	Webster et al.	Apr 1996	A
5507773	Hutema et al.	Apr 1996	A
5509916	Taylor et al.	Apr 1996	A
5514129	Smith	May 1996	A
5514134	Rydell et al.	May 1996	A
5518163	Hooven	May 1996	A
5518164	Hooven	May 1996	A
5527313	Scott et al.	Jun 1996	A
5527330	Tovey	Jun 1996	A
5531744	Nardella et al.	Jul 1996	A
5540681	Strul et al.	Jul 1996	A
5540684	Hassler et al.	Jul 1996	A
5540685	Parins et al.	Jul 1996	A
5541376	Ladtkow et al.	Jul 1996	A
5551945	Yabe et al.	Sep 1996	A
5558429	Cain	Sep 1996	A
5558671	Yates	Sep 1996	A
5562699	Heimberger et al.	Oct 1996	A
5562700	Huitema et al.	Oct 1996	A
5571100	Goble et al.	Nov 1996	A
5571121	Heifetz	Nov 1996	A
5573424	Poppe	Nov 1996	A
5573533	Strul	Nov 1996	A
5573534	Stone	Nov 1996	A
5573535	Viklund	Nov 1996	A
5575789	Bell et al.	Nov 1996	A
5575805	Li	Nov 1996	A
5584830	Ladd et al.	Dec 1996	A
5599344	Paterson	Feb 1997	A
5599350	Schulze et al.	Feb 1997	A
5603711	Parins et al.	Feb 1997	A
D378611	Croley	Mar 1997	S
5607391	Klinger et al.	Mar 1997	A
5609151	Mulier et al.	Mar 1997	A
5609560	Ichikawa et al.	Mar 1997	A
5609573	Sandock	Mar 1997	A
5611709	McAnulty	Mar 1997	A
5613966	Makower et al.	Mar 1997	A
5620415	Lucey et al.	Apr 1997	A
5620447	Smith et al.	Apr 1997	A
5624452	Yates	Apr 1997	A
5626575	Crenner	May 1997	A
5626607	Malecki et al.	May 1997	A
5626608	Cuny et al.	May 1997	A
5627584	Nishikori et al.	May 1997	A
5633578	Eggers et al.	May 1997	A
5645540	Henniges et al.	Jul 1997	A
5647869	Goble et al.	Jul 1997	A
5651780	Jackson et al.	Jul 1997	A
5658279	Nardella et al.	Aug 1997	A
5658281	Heard	Aug 1997	A
5665100	Yoon	Sep 1997	A
5665105	Furnish et al.	Sep 1997	A
5667517	Hooven	Sep 1997	A
5669907	Platt, Jr. et al.	Sep 1997	A
5674184	Hassler, Jr.	Oct 1997	A
5674220	Fox et al.	Oct 1997	A
5683349	Makower et al.	Nov 1997	A
5688270	Yates et al.	Nov 1997	A
5693045	Eggers	Dec 1997	A
5693051	Schulze et al.	Dec 1997	A
5695494	Becker	Dec 1997	A
5697281	Eggers et al.	Dec 1997	A
5697909	Eggers et al.	Dec 1997	A
5700261	Brinkerhoff	Dec 1997	A
5702386	Stern et al.	Dec 1997	A
5702387	Arts et al.	Dec 1997	A
5702390	Austin et al.	Dec 1997	A
5707369	Vaitekunas et al.	Jan 1998	A
5709680	Yates et al.	Jan 1998	A
5713128	Schrenk et al.	Feb 1998	A
5713895	Lontine et al.	Feb 1998	A
5713896	Nardella	Feb 1998	A
5720293	Quinn et al.	Feb 1998	A
5720742	Zacharias	Feb 1998	A
5720744	Eggleston et al.	Feb 1998	A
5720745	Farin et al.	Feb 1998	A
5722975	Edwards et al.	Mar 1998	A
5725524	Mulier et al.	Mar 1998	A
5735848	Yates et al.	Apr 1998	A
5735849	Baden et al.	Apr 1998	A
5743456	Jones et al.	Apr 1998	A
5743906	Parins et al.	Apr 1998	A
5746210	Benaron et al.	May 1998	A
5746740	Nicholas	May 1998	A
5746759	Meade et al.	May 1998	A
5752519	Benaron et al.	May 1998	A
5755717	Yates et al.	May 1998	A
5759185	Grinberg	Jun 1998	A
5762609	Benaron et al.	Jun 1998	A
5766167	Eggers et al.	Jun 1998	A
5769791	Benaron et al.	Jun 1998	A
5769841	Odell et al.	Jun 1998	A
5772597	Goldberger et al.	Jun 1998	A
5772659	Seeker et al.	Jun 1998	A
5772660	Young et al.	Jun 1998	A
5776092	Farin et al.	Jul 1998	A
5776129	Mersch	Jul 1998	A
5776130	Buysse et al.	Jul 1998	A
5776155	Beaupre et al.	Jul 1998	A
5782397	Koukline	Jul 1998	A
5785658	Benaron et al.	Jul 1998	A
5792139	Chambers et al.	Aug 1998	A
5792178	Welch et al.	Aug 1998	A
5797906	Rhum et al.	Aug 1998	A
5797938	Paraschac et al.	Aug 1998	A
5797941	Schulze	Aug 1998	A
5800449	Wales	Sep 1998	A
5807261	Benaron et al.	Sep 1998	A
5807393	Williamson, IV et al.	Sep 1998	A
5807395	Mulier et al.	Sep 1998	A
5810806	Ritchart et al.	Sep 1998	A
5810811	Yates et al.	Sep 1998	A
5810859	Dimatteo et al.	Sep 1998	A
5817091	Nardella et al.	Oct 1998	A
5817093	Williamson, IV et al.	Oct 1998	A
5817119	Klieman et al.	Oct 1998	A
5827271	Buysse et al.	Oct 1998	A
5827279	Hughett et al.	Oct 1998	A
5827299	Thomason et al.	Oct 1998	A
5830231	Geiges, Jr.	Nov 1998	A
5833690	Yates et al.	Nov 1998	A
5836942	Netherly et al.	Nov 1998	A
5836943	Miller, III	Nov 1998	A
5846194	Wasson et al.	Dec 1998	A
5849020	Long et al.	Dec 1998	A
5853412	Mayenbergr	Dec 1998	A
5860975	Goble et al.	Jan 1999	A
5873873	Smith et al.	Feb 1999	A
5876398	Mulier et al.	Mar 1999	A
5876401	Schulze et al.	Mar 1999	A
5885277	Korth	Mar 1999	A
5891095	Eggers et al.	Apr 1999	A
5891141	Rydell	Apr 1999	A
5891142	Eggers et al.	Apr 1999	A
5893835	Witt et al.	Apr 1999	A
5893873	Rader et al.	Apr 1999	A
5897490	Fox et al.	Apr 1999	A
5897523	Wright et al.	Apr 1999	A
5897553	Mulier et al.	Apr 1999	A
5897569	Kellogg et al.	Apr 1999	A
5902264	Toso et al.	May 1999	A
5902301	Olig	May 1999	A
5904709	Arndt et al.	May 1999	A
5906613	Mulier et al.	May 1999	A
5908402	Blythe	Jun 1999	A
5908420	Parins et al.	Jun 1999	A
5910152	Bays	Jun 1999	A
5928137	Green	Jul 1999	A
5928255	Meade et al.	Jul 1999	A
5928256	Riza	Jul 1999	A
5931836	Hatta et al.	Aug 1999	A
5935126	Riza	Aug 1999	A
5938633	Beaupre	Aug 1999	A
5944715	Goble et al.	Aug 1999	A
5944718	Austin et al.	Aug 1999	A
5944737	Tsonton et al.	Aug 1999	A
5947284	Foster	Sep 1999	A
5947984	Whipple	Sep 1999	A
5951552	Long et al.	Sep 1999	A
5954736	Bishop et al.	Sep 1999	A
5954746	Holthaus et al.	Sep 1999	A
5957943	Vaitekunas	Sep 1999	A
5961514	Long et al.	Oct 1999	A
5968062	Thomas et al.	Oct 1999	A
5968074	Prestel	Oct 1999	A
5976077	Wittens et al.	Nov 1999	A
5976128	Schilling et al.	Nov 1999	A
5980510	Tsonton et al.	Nov 1999	A
5980516	Mulier et al.	Nov 1999	A
5984921	Long et al.	Nov 1999	A
5987346	Benaron et al.	Nov 1999	A
5993380	Yabe et al.	Nov 1999	A
5993447	Blewett et al.	Nov 1999	A
5995875	Blewett et al.	Nov 1999	A
5997533	Kuhns	Dec 1999	A
6003517	Sheffield et al.	Dec 1999	A
6004319	Goble et al.	Dec 1999	A
6004335	Vaitekunas et al.	Dec 1999	A
6010499	Cobb	Jan 2000	A
6010516	Hulka	Jan 2000	A
6013076	Goble et al.	Jan 2000	A
6015406	Goble et al.	Jan 2000	A
6016809	Mulier et al.	Jan 2000	A
D420741	Croley	Feb 2000	S
6024741	Williamson, IV et al.	Feb 2000	A
6024744	Kese et al.	Feb 2000	A
6027501	Goble et al.	Feb 2000	A
6027522	Palmer	Feb 2000	A
6030384	Nezhat	Feb 2000	A
6030402	Thompson et al.	Feb 2000	A
6033399	Gines	Mar 2000	A
6033404	Melzer et al.	Mar 2000	A
6036657	Milliman et al.	Mar 2000	A
6039733	Buysse et al.	Mar 2000	A
6039734	Goble et al.	Mar 2000	A
6039736	Platt, Jr.	Mar 2000	A
6050996	Schmaltz et al.	Apr 2000	A
6051010	Dimatteo et al.	Apr 2000	A
6053172	Hovda et al.	Apr 2000	A
6053914	Eggers et al.	Apr 2000	A
6056746	Goble et al.	May 2000	A
6063050	Manna et al.	May 2000	A
6063075	Mohori	May 2000	A
6063081	Mulier et al.	May 2000	A
6063086	Benecke et al.	May 2000	A
6066139	Ryan et al.	May 2000	A
6068627	Orszulak et al.	May 2000	A
6068647	Witt et al.	May 2000	A
6070444	Lontine et al.	Jun 2000	A
6074386	Goble et al.	Jun 2000	A
RE36795	Rydell	Jul 2000	E
6083191	Rose	Jul 2000	A
6086586	Hooven	Jul 2000	A
6090106	Goble et al.	Jul 2000	A
6090120	Wright et al.	Jul 2000	A
6092722	Heinrichs et al.	Jul 2000	A
6093186	Goble	Jul 2000	A
6096037	Mulier et al.	Aug 2000	A
6102909	Chen et al.	Aug 2000	A
6106521	Blewett et al.	Aug 2000	A
6109268	Thapliyal et al.	Aug 2000	A
6110171	Rydell	Aug 2000	A
6113591	Whayne et al.	Sep 2000	A
6113594	Savage	Sep 2000	A
6113596	Hooven et al.	Sep 2000	A
6113598	Baker	Sep 2000	A
6117152	Huitema	Sep 2000	A
6120501	Long et al.	Sep 2000	A
H1904	Yates	Oct 2000	H
6132429	Baker	Oct 2000	A
6135998	Palanker	Oct 2000	A
6139519	Blythe	Oct 2000	A
6139547	Lontine et al.	Oct 2000	A
6142992	Cheng et al.	Nov 2000	A
6152923	Ryan	Nov 2000	A
6159146	El Gazayerli	Dec 2000	A
6162235	Vaitekunas	Dec 2000	A
6165175	Wampler et al.	Dec 2000	A
6168605	Measamer et al.	Jan 2001	B1
6171304	Netherly et al.	Jan 2001	B1
6174308	Goble et al.	Jan 2001	B1
6174309	Wrublewski et al.	Jan 2001	B1
6179834	Buysse et al.	Jan 2001	B1
6186147	Cobb	Feb 2001	B1
6187003	Buysse et al.	Feb 2001	B1
6187026	Devlin et al.	Feb 2001	B1
6190383	Schmaltz et al.	Feb 2001	B1
6190385	Tom et al.	Feb 2001	B1
6190386	Rydell	Feb 2001	B1
6193129	Bittner et al.	Feb 2001	B1
6193653	Evans et al.	Feb 2001	B1
6193713	Geistert et al.	Feb 2001	B1
6197026	Farin et al.	Mar 2001	B1
6203541	Keppel	Mar 2001	B1
6206823	Kolata et al.	Mar 2001	B1
6206844	Reichel et al.	Mar 2001	B1
6206875	Long et al.	Mar 2001	B1
6206877	Kese et al.	Mar 2001	B1
6210403	Klicek	Apr 2001	B1
6210405	Goble et al.	Apr 2001	B1
6214003	Morgan et al.	Apr 2001	B1
6214023	Whipple et al.	Apr 2001	B1
6228023	Zaslavsky et al.	May 2001	B1
6228055	Foerster et al.	May 2001	B1
6228080	Gines	May 2001	B1
6228081	Goble	May 2001	B1
6228083	Lands et al.	May 2001	B1
6234178	Goble et al.	May 2001	B1
6237604	Burnside et al.	May 2001	B1
6238366	Savage et al.	May 2001	B1
6238392	Long	May 2001	B1
6238393	Mulier et al.	May 2001	B1
6242741	Miller et al.	Jun 2001	B1
6246912	Sluijter et al.	Jun 2001	B1
6251106	Becker et al.	Jun 2001	B1
6251110	Wampler	Jun 2001	B1
6254623	Haibel et al.	Jul 2001	B1
6257241	Wampler	Jul 2001	B1
6258085	Eggleston	Jul 2001	B1
6261286	Goble et al.	Jul 2001	B1
6267761	Ryan	Jul 2001	B1
6270497	Sekino et al.	Aug 2001	B1
6273862	Privitera et al.	Aug 2001	B1
6277114	Bullivant et al.	Aug 2001	B1
6277115	Saadat	Aug 2001	B1
6277117	Tetzlaff et al.	Aug 2001	B1
6280398	Ritchart et al.	Aug 2001	B1
6280407	Manna et al.	Aug 2001	B1
6280441	Ryan	Aug 2001	B1
6283963	Regula	Sep 2001	B1
6287344	Wampler	Sep 2001	B1
6293942	Goble et al.	Sep 2001	B1
6293945	Parins et al.	Sep 2001	B1
6296637	Thorne et al.	Oct 2001	B1
6296640	Wampler et al.	Oct 2001	B1
6298550	Kirwan, Jr.	Oct 2001	B1
6302903	Mulier et al.	Oct 2001	B1
6306131	Hareyama et al.	Oct 2001	B1
6306134	Goble et al.	Oct 2001	B1
6308089	von der Ruhr et al.	Oct 2001	B1
6309400	Beaupre	Oct 2001	B2
6312426	Goldberg et al.	Nov 2001	B1
6315777	Comben	Nov 2001	B1
6319221	Savage et al.	Nov 2001	B1
6322494	Bullivant et al.	Nov 2001	B1
6322549	Eggers et al.	Nov 2001	B1
6322561	Eggers et al.	Nov 2001	B1
6325795	Lindemann et al.	Dec 2001	B1
6325799	Goble	Dec 2001	B1
6325811	Messerly	Dec 2001	B1
6328736	Mulier et al.	Dec 2001	B1
6328751	Beaupre	Dec 2001	B1
6331181	Tierney et al.	Dec 2001	B1
6334068	Hacker	Dec 2001	B1
6334861	Chandler et al.	Jan 2002	B1
6336926	Goble et al.	Jan 2002	B1
6348051	Farin et al.	Feb 2002	B1
6352532	Kramer et al.	Mar 2002	B1
6352536	Buysse et al.	Mar 2002	B1
6358248	Mulier et al.	Mar 2002	B1
6358249	Chen et al.	Mar 2002	B1
6358267	Murakami	Mar 2002	B1
6361534	Chen et al.	Mar 2002	B1
6364877	Goble et al.	Apr 2002	B1
6364879	Chen et al.	Apr 2002	B1
6371967	Long et al.	Apr 2002	B1
D457958	Dycus	May 2002	S
6383183	Sekino et al.	May 2002	B1
6387092	Burnside et al.	May 2002	B1
6387109	Davison et al.	May 2002	B1
6391024	Sun et al.	May 2002	B1
6391025	Weinstein et al.	May 2002	B1
6398779	Buysse et al.	Jun 2002	B1
6398781	Goble et al.	Jun 2002	B1
6402741	Keppel et al.	Jun 2002	B1
6402742	Blewett et al.	Jun 2002	B1
6402743	Orszulak et al.	Jun 2002	B1
6402747	Lindemann et al.	Jun 2002	B1
6402748	Schoenman et al.	Jun 2002	B1
6406475	Wenzler et al.	Jun 2002	B1
6409722	Hoey et al.	Jun 2002	B1
6409724	Penny et al.	Jun 2002	B1
6409728	Ehr et al.	Jun 2002	B1
6416486	Wampler	Jul 2002	B1
6416509	Goble et al.	Jul 2002	B1
6423057	He et al.	Jul 2002	B1
6423082	Houser et al.	Jul 2002	B1
6432118	Messerly	Aug 2002	B1
6436096	Hareyama	Aug 2002	B1
6440130	Mulier et al.	Aug 2002	B1
6443952	Mulier et al.	Sep 2002	B1
6443968	Holthaus et al.	Sep 2002	B1
6443970	Schulze et al.	Sep 2002	B1
6451013	Bays et al.	Sep 2002	B1
6451018	Lands et al.	Sep 2002	B1
6454764	Fleenor et al.	Sep 2002	B1
6454781	Witt et al.	Sep 2002	B1
6454782	Schwemberger	Sep 2002	B1
6458078	Luedtke et al.	Oct 2002	B1
6458128	Schulze	Oct 2002	B1
6458130	Frazier et al.	Oct 2002	B1
6458142	Faller et al.	Oct 2002	B1
6461352	Morgan et al.	Oct 2002	B2
6464689	Qin et al.	Oct 2002	B1
6464702	Schulze et al.	Oct 2002	B2
6464704	Schmaltz et al.	Oct 2002	B2
6468275	Wampler et al.	Oct 2002	B1
6468286	Mastri et al.	Oct 2002	B2
6475217	Platt	Nov 2002	B1
6478030	Shaoeton et al.	Nov 2002	B1
6482202	Goble et al.	Nov 2002	B1
6485490	Wampler et al.	Nov 2002	B2
6488507	Stoloff et al.	Dec 2002	B1
6488680	Francischelli et al.	Dec 2002	B1
6491690	Goble et al.	Dec 2002	B1
6491708	Madan et al.	Dec 2002	B2
6493589	Medhkour et al.	Dec 2002	B1
6494877	Odell et al.	Dec 2002	B2
6494902	Hoey et al.	Dec 2002	B2
6497705	Comben	Dec 2002	B2
6500176	Truckai et al.	Dec 2002	B1
6500188	Harper et al.	Dec 2002	B2
6503263	Adams	Jan 2003	B2
6506189	Rittman et al.	Jan 2003	B1
6506208	Hunt et al.	Jan 2003	B2
6510854	Goble et al.	Jan 2003	B2
6511476	Hareyama	Jan 2003	B2
6511480	Tetzlaff et al.	Jan 2003	B1
6514252	Nezhat et al.	Feb 2003	B2
6517536	Hooven et al.	Feb 2003	B2
6517538	Jacob et al.	Feb 2003	B1
6526320	Mitchell	Feb 2003	B2
6527771	Weadock et al.	Mar 2003	B1
6533784	Truckai et al.	Mar 2003	B2
6534770	Miller et al.	Mar 2003	B2
6537248	Mulier et al.	Mar 2003	B2
6537272	Christopherson et al.	Mar 2003	B2
6540695	Burbank et al.	Apr 2003	B1
6543456	Freeman	Apr 2003	B1
6547783	Vilendrer et al.	Apr 2003	B1
6547786	Goble et al.	Apr 2003	B1
6554829	Schulze et al.	Apr 2003	B2
6558379	Batchelor et al.	May 2003	B1
6558383	Cunningham et al.	May 2003	B2
6561983	Cronin et al.	May 2003	B2
6562037	Paton et al.	May 2003	B2
6565559	Eggleston	May 2003	B2
6565560	Goble et al.	May 2003	B1
6569105	Kortenbach et al.	May 2003	B1
6569109	Sakurai et al.	May 2003	B2
6572615	Schulze et al.	Jun 2003	B2
6579289	Schnitzler	Jun 2003	B2
6582424	Fleenor et al.	Jun 2003	B2
6582427	Goble et al.	Jun 2003	B1
6584360	Francischelli et al.	Jun 2003	B2
D477408	Bromley	Jul 2003	S
6585732	Mulier et al.	Jul 2003	B2
6585733	Wellman	Jul 2003	B2
6585735	Frazier et al.	Jul 2003	B1
6589200	Schwemberger et al.	Jul 2003	B1
6591719	Poole et al.	Jul 2003	B1
6592582	Hess et al.	Jul 2003	B2
6594518	Benaron et al.	Jul 2003	B1
6602227	Cimino et al.	Aug 2003	B1
6602249	Stoddard et al.	Aug 2003	B1
6602252	Mollenauer	Aug 2003	B2
6605036	Wild	Aug 2003	B1
6607529	Jones et al.	Aug 2003	B1
6610060	Mulier et al.	Aug 2003	B2
6611793	Burnside et al.	Aug 2003	B1
6613048	Mulier et al.	Sep 2003	B2
6616656	Brommersma	Sep 2003	B2
6616660	Platt	Sep 2003	B1
6616661	Wellman et al.	Sep 2003	B2
6620157	Dabney et al.	Sep 2003	B1
6620161	Schulze et al.	Sep 2003	B2
6623482	Pendekanti et al.	Sep 2003	B2
6623515	Mulier et al.	Sep 2003	B2
6626901	Treat et al.	Sep 2003	B1
6629974	Penny et al.	Oct 2003	B2
6638274	Yamamoto	Oct 2003	B2
6648883	Francischelli et al.	Nov 2003	B2
6652514	Ellman et al.	Nov 2003	B2
6652521	Schulze	Nov 2003	B2
6656110	Irion et al.	Dec 2003	B1
6656175	Francischelli et al.	Dec 2003	B2
6656176	Hess et al.	Dec 2003	B2
6656177	Truckai et al.	Dec 2003	B2
6660017	Beaupre	Dec 2003	B2
6662050	Olson	Dec 2003	B2
6662127	Wiener et al.	Dec 2003	B2
6663622	Foley et al.	Dec 2003	B1
6663627	Francischelli et al.	Dec 2003	B2
6663628	Peters	Dec 2003	B2
6666865	Platt	Dec 2003	B2
6676660	Wampler et al.	Jan 2004	B2
6678621	Wiener et al.	Jan 2004	B2
6679882	Kornerup	Jan 2004	B1
6682527	Strul	Jan 2004	B2
6682528	Frazier et al.	Jan 2004	B2
6682544	Mastri et al.	Jan 2004	B2
6685701	Orszulak et al.	Feb 2004	B2
6685703	Pearson et al.	Feb 2004	B2
6692450	Coleman	Feb 2004	B1
6692489	Heim et al.	Feb 2004	B1
6695837	Howell	Feb 2004	B2
6695838	Wellman et al.	Feb 2004	B2
6695840	Schulze	Feb 2004	B2
6699240	Francischelli et al.	Mar 2004	B2
6706038	Francischelli et al.	Mar 2004	B2
6706039	Mulier et al.	Mar 2004	B2
6709432	Ferek-Petric	Mar 2004	B2
6723091	Goble et al.	Apr 2004	B2
6726683	Shaw	Apr 2004	B1
6726686	Buysse et al.	Apr 2004	B2
6733498	Paton et al.	May 2004	B2
6736810	Hoey et al.	May 2004	B2
6740084	Ryan	May 2004	B2
6740085	Hareyama et al.	May 2004	B2
6740102	Hess et al.	May 2004	B2
6743229	Buysse	Jun 2004	B2
6752804	Simpson et al.	Jun 2004	B2
6755825	Schoenman et al.	Jun 2004	B2
6755827	Mulier et al.	Jun 2004	B2
6755841	Fraser et al.	Jun 2004	B2
6758846	Goble et al.	Jul 2004	B2
6764487	Mulier et al.	Jul 2004	B2
6770071	Woloszko et al.	Aug 2004	B2
6770072	Truckai et al.	Aug 2004	B1
6773409	Truckai et al.	Aug 2004	B2
6773434	Ciarrocca	Aug 2004	B2
6773435	Schulze et al.	Aug 2004	B2
6773444	Messerly	Aug 2004	B2
6775575	Bommannan et al.	Aug 2004	B2
6776780	Mulier et al.	Aug 2004	B2
6780180	Goble et al.	Aug 2004	B1
6786906	Cobb	Sep 2004	B1
6790217	Schulze et al.	Sep 2004	B2
6796828	Ehr et al.	Sep 2004	B2
6796981	Wham et al.	Sep 2004	B2
6807444	Tu et al.	Oct 2004	B2
6807968	Francischelli et al.	Oct 2004	B2
6808518	Wellman et al.	Oct 2004	B2
6808525	Latterell et al.	Oct 2004	B2
6814745	Prestel	Nov 2004	B2
6821273	Mollenauer	Nov 2004	B2
6827715	Francischelli et al.	Dec 2004	B2
6827717	Brommersma et al.	Dec 2004	B2
6827725	Batchelor et al.	Dec 2004	B2
6830569	Thompson et al.	Dec 2004	B2
6832111	Tu et al.	Dec 2004	B2
6832985	Irion et al.	Dec 2004	B2
6832998	Goble	Dec 2004	B2
6835082	Gonnering	Dec 2004	B2
6835195	Schulze et al.	Dec 2004	B2
6837887	Woloszko et al.	Jan 2005	B2
6843789	Goble	Jan 2005	B2
6849073	Hoy et al.	Feb 2005	B2
6852112	Platt	Feb 2005	B2
6855142	Harano et al.	Feb 2005	B2
6855145	Ciarrocca	Feb 2005	B2
6858028	Mulier et al.	Feb 2005	B2
6860881	Sturm	Mar 2005	B2
6860894	Pittman	Mar 2005	B1
6887240	Lands et al.	May 2005	B1
6889694	Hooven	May 2005	B2
6893435	Goble	May 2005	B2
6893441	Brommersma et al.	May 2005	B2
6899710	Hooven	May 2005	B2
6905497	Truckai et al.	Jun 2005	B2
6905498	Hooven	Jun 2005	B2
6908472	Wiener et al.	Jun 2005	B2
6911019	Mulier et al.	Jun 2005	B2
6913579	Truckai et al.	Jul 2005	B2
6916318	Francischelli et al.	Jul 2005	B2
6918880	Brookner et al.	Jul 2005	B2
6923803	Goble	Aug 2005	B2
6923804	Eggers et al.	Aug 2005	B2
6923806	Hooven et al.	Aug 2005	B2
6926716	Baker et al.	Aug 2005	B2
6929641	Goble et al.	Aug 2005	B2
6929644	Truckai et al.	Aug 2005	B2
6932810	Ryan	Aug 2005	B2
6932811	Hooven et al.	Aug 2005	B2
6937033	Boronkay et al.	Aug 2005	B2
6939347	Thompson	Sep 2005	B2
6942660	Pantera et al.	Sep 2005	B2
6942662	Goble et al.	Sep 2005	B2
6945972	Frigg et al.	Sep 2005	B2
6945981	Donofrio et al.	Sep 2005	B2
6948503	Refior et al.	Sep 2005	B2
6949098	Mulier et al.	Sep 2005	B2
6958063	Soil et al.	Oct 2005	B1
6960209	Clague et al.	Nov 2005	B2
6960210	Lands et al.	Nov 2005	B2
6962587	Johnson et al.	Nov 2005	B2
6962589	Mulier et al.	Nov 2005	B2
6966907	Goble	Nov 2005	B2
6966909	Marshall et al.	Nov 2005	B2
6971988	Orban et al.	Dec 2005	B2
6974453	Woloszko et al.	Dec 2005	B2
6974454	Hooven	Dec 2005	B2
6976969	Messerly	Dec 2005	B2
6979332	Adams	Dec 2005	B2
6984231	Goble et al.	Jan 2006	B2
6984233	Hooven	Jan 2006	B2
6984826	Miller et al.	Jan 2006	B2
6989010	Francischelli et al.	Jan 2006	B2
6994705	Nobis et al.	Feb 2006	B2
6997735	Ehr et al.	Feb 2006	B2
6997935	Anderson et al.	Feb 2006	B2
7001380	Goble	Feb 2006	B2
7001415	Hooven	Feb 2006	B2
7011657	Truckai et al.	Mar 2006	B2
7025764	Paton et al.	Apr 2006	B2
7029470	Francischelli et al.	Apr 2006	B2
7033351	Howell	Apr 2006	B2
7033354	Keppel	Apr 2006	B2
7033356	Latterell	Apr 2006	B2
7041096	Malis	May 2006	B2
7041102	Truckai et al.	May 2006	B2
7044948	Keppel	May 2006	B2
7044949	Orszulak	May 2006	B2
7044950	Yamamoto	May 2006	B2
7048687	Reuss et al.	May 2006	B1
7049599	Miller et al.	May 2006	B2
7052494	Goble et al.	May 2006	B2
7060063	Marion et al.	Jun 2006	B2
7063699	Hess	Jun 2006	B2
7066933	Hagg	Jun 2006	B2
7066936	Ryan	Jun 2006	B2
7070597	Truckai et al.	Jul 2006	B2
7074218	Washington et al.	Jul 2006	B2
7074219	Levine et al.	Jul 2006	B2
7083618	Couture et al.	Aug 2006	B2
7083619	Truckai et al.	Aug 2006	B2
7083620	Jahns et al.	Aug 2006	B2
7087054	Truckai et al.	Aug 2006	B2
7090673	Dycus	Aug 2006	B2
7094202	Nobis et al.	Aug 2006	B2
7094235	Francischelli	Aug 2006	B2
7097644	Long	Aug 2006	B2
7101371	Dycus et al.	Sep 2006	B2
7101372	Dycus et al.	Sep 2006	B2
7101373	Dycus et al.	Sep 2006	B2
7103947	Sartor et al.	Sep 2006	B2
7104834	Robinson et al.	Sep 2006	B2
7104989	Skarda	Sep 2006	B2
7108695	Witt et al.	Sep 2006	B2
7111769	Wales et al.	Sep 2006	B2
7112201	Truckai et al.	Sep 2006	B2
RE39358	Goble	Oct 2006	E
7116157	Ross	Oct 2006	B2
7118564	Ritchie et al.	Oct 2006	B2
7118570	Tetzlaff et al.	Oct 2006	B2
7118587	Dycus et al.	Oct 2006	B2
7119516	Denning	Oct 2006	B2
7124932	Isaacson	Oct 2006	B2
7125409	Truckai et al.	Oct 2006	B2
7126125	Miller et al.	Oct 2006	B2
7131445	Amoah	Nov 2006	B2
7131860	Sartor	Nov 2006	B2
7131970	Moses et al.	Nov 2006	B2
7131971	Dycus et al.	Nov 2006	B2
7135018	Ryan et al.	Nov 2006	B2
7135020	Lawes et al.	Nov 2006	B2
7137980	Buysse	Nov 2006	B2
D533942	Kerr et al.	Dec 2006	S
7147635	Ciarrocca	Dec 2006	B2
7147637	Goble	Dec 2006	B2
7147638	Chapman et al.	Dec 2006	B2
7150097	Sremcich	Dec 2006	B2
7150748	Ebbutt	Dec 2006	B2
7150749	Dycus et al.	Dec 2006	B2
7153300	Goble	Dec 2006	B2
7156843	Skarda	Jan 2007	B2
7156845	Mulier et al.	Jan 2007	B2
7156846	Dycus et al.	Jan 2007	B2
7159750	Racenet et al.	Jan 2007	B2
7160293	Sturm et al.	Jan 2007	B2
7160298	Lawes et al.	Jan 2007	B2
7160299	Baily	Jan 2007	B2
7163548	Stulen et al.	Jan 2007	B2
7166105	Mulier et al.	Jan 2007	B2
7169115	Nobis et al.	Jan 2007	B2
7169144	Hoey	Jan 2007	B2
7169145	Isaacson	Jan 2007	B2
7169146	Truckai et al.	Jan 2007	B2
7172591	Harano et al.	Feb 2007	B2
7179254	Pendkanti	Feb 2007	B2
7179258	Buysse et al.	Feb 2007	B2
7182604	Ehr et al.	Feb 2007	B2
7186252	Nobis et al.	Mar 2007	B2
7186253	Truckai et al.	Mar 2007	B2
7187790	Sabol	Mar 2007	B2
7189231	Clague et al.	Mar 2007	B2
7189232	Scholl et al.	Mar 2007	B2
7189233	Truckai et al.	Mar 2007	B2
7191015	Lamson et al.	Mar 2007	B2
7195627	Amoah	Mar 2007	B2
7195630	Ciarrocca	Mar 2007	B2
7195631	Dumbauld	Mar 2007	B2
7204835	Latterell et al.	Apr 2007	B2
7207471	Heinrich et al.	Apr 2007	B2
7207990	Lands et al.	Apr 2007	B2
D541938	Kerr et al.	May 2007	S
7211081	Goble	May 2007	B2
7211084	Goble	May 2007	B2
7214224	Goble	May 2007	B2
7216001	Hacker et al.	May 2007	B2
7220260	Fleming	May 2007	B2
7220951	Truckai et al.	May 2007	B2
7223239	Schulze et al.	May 2007	B2
7223265	Keppel	May 2007	B2
7226447	Uchida	Jun 2007	B2
7229307	Ehr et al.	Jun 2007	B2
7232439	Ciarrocca	Jun 2007	B2
7232440	Dumbald et al.	Jun 2007	B2
7235048	Rein et al.	Jun 2007	B2
7235072	Sartor et al.	Jun 2007	B2
7235073	Levine et al.	Jun 2007	B2
7237708	Guy	Jul 2007	B1
7241296	Buysse et al.	Jul 2007	B2
7247141	Makin et al.	Jul 2007	B2
7247155	Hoey et al.	Jul 2007	B2
7250048	Francischelli et al.	Jul 2007	B2
7250051	Francischelli	Jul 2007	B2
7252667	Moses	Aug 2007	B2
7255694	Keppel	Aug 2007	B2
7255696	Goble et al.	Aug 2007	B2
7255697	Dycus et al.	Aug 2007	B2
7259340	Blaha et al.	Aug 2007	B2
7261711	Mulier et al.	Aug 2007	B2
7267677	Johnson et al.	Sep 2007	B2
7270660	Ryan	Sep 2007	B2
7270664	Johnson et al.	Sep 2007	B2
7273483	Weiner et al.	Sep 2007	B2
7276068	Johnson et al.	Oct 2007	B2
7278994	Goble	Oct 2007	B2
7282048	Goble et al.	Oct 2007	B2
7282049	Oraszulak et al.	Oct 2007	B2
7291161	Hooven	Nov 2007	B2
7297145	Woloszko et al.	Nov 2007	B2
7300435	Wham et al.	Nov 2007	B2
7300446	Beaupre	Nov 2007	B2
7300450	Vleugels et al.	Nov 2007	B2
7303557	Wham	Dec 2007	B2
7309325	Mulier et al.	Dec 2007	B2
7309849	Truckai et al.	Dec 2007	B2
7311560	Ehr et al.	Dec 2007	B2
7311706	Schoenman et al.	Dec 2007	B2
7311707	Hagg et al.	Dec 2007	B2
7311709	Truckai et al.	Dec 2007	B2
7322975	Goble et al.	Jan 2008	B2
7329256	Johnson et al.	Feb 2008	B2
7335997	Weiner	Feb 2008	B2
7344532	Goble et al.	Mar 2008	B2
7347858	Francischelli et al.	Mar 2008	B2
RE40279	Sluijter et al.	Apr 2008	E
D567943	Moses et al.	Apr 2008	S
7353068	Tanake et al.	Apr 2008	B2
7354435	Farin et al.	Apr 2008	B2
7354440	Truckai et al.	Apr 2008	B2
7354443	Moll et al.	Apr 2008	B2
7364577	Wham et al.	Apr 2008	B2
7364578	Francischelli et al.	Apr 2008	B2
7364579	Miller et al.	Apr 2008	B2
7367972	Francischelli et al.	May 2008	B2
7367976	Lawes et al.	May 2008	B2
7371246	Viola	May 2008	B2
7377902	Burbank et al.	May 2008	B2
7377918	Amoah	May 2008	B2
7377920	Buysse et al.	May 2008	B2
RE40388	Gines	Jun 2008	E
7381209	Truckai et al.	Jun 2008	B2
7384420	Dycus et al.	Jun 2008	B2
7384421	Hushka	Jun 2008	B2
7396336	Orszulak et al.	Jul 2008	B2
D575395	Hushka	Aug 2008	S
D575401	Hixson et al.	Aug 2008	S
7416101	Shelton	Aug 2008	B2
7416437	Sartor et al.	Aug 2008	B2
7419487	Johnson et al.	Sep 2008	B2
7422139	Shelton et al.	Sep 2008	B2
7422588	Mulier et al.	Sep 2008	B2
7424965	Racenet et al.	Sep 2008	B2
7425835	Eisele	Sep 2008	B2
7426415	Kuhner	Sep 2008	B2
7431720	Pendekanti et al.	Oct 2008	B2
7431721	Paton et al.	Oct 2008	B2
7435249	Buysse et al.	Oct 2008	B2
7435250	Francischelli et al.	Oct 2008	B2
7442167	Dunki-Jacobs	Oct 2008	B2
7442193	Shelds	Oct 2008	B2
7442194	Dumbauld	Oct 2008	B2
7445621	Dumbauld et al.	Nov 2008	B2
7458972	Keppel	Dec 2008	B2
7464846	Shelton et al.	Dec 2008	B2
7470272	Mulier et al.	Dec 2008	B2
7473250	Makin et al.	Jan 2009	B2
7473253	Dycus et al.	Jan 2009	B2
7476233	Wiener et al.	Jan 2009	B1
7481808	Koyfman et al.	Jan 2009	B2
7491199	Goble et al.	Feb 2009	B2
7497858	Chapelon et al.	Mar 2009	B2
7811283	Moses et al.	Oct 2010	B2
7841765	Keller	Nov 2010	B2
8561615	Pannell et al.	Oct 2013	B2
8784417	Hanna	Jul 2014	B2
8808288	Rescheke	Aug 2014	B2
9161813	Benamou	Oct 2015	B2
20010037110	Schmaltz	Nov 2001	A1
20010039417	Harano et al.	Nov 2001	A1
20020052599	Goble	May 2002	A1
20020115997	Truckai	Aug 2002	A1
20020120262	Bek	Aug 2002	A1
20020120266	Truckai	Aug 2002	A1
20020128650	McClurken	Sep 2002	A1
20020151884	Hoey et al.	Oct 2002	A1
20020161363	Fodor et al.	Oct 2002	A1
20020165541	Whitman	Nov 2002	A1
20020188294	Couture et al.	Dec 2002	A1
20030004510	Wham	Jan 2003	A1
20030014052	Buysse	Jan 2003	A1
20030060818	Kannenberg et al.	Mar 2003	A1
20030065327	Wellman	Apr 2003	A1
20030065358	Frecker et al.	Apr 2003	A1
20030069571	Treat	Apr 2003	A1
20030109871	Johnson	Jun 2003	A1
20030114845	Paton et al.	Jun 2003	A1
20030114848	Cobb	Jun 2003	A1
20030114851	Truckai et al.	Jun 2003	A1
20030125728	Nezhat et al.	Jul 2003	A1
20030125731	Smith et al.	Jul 2003	A1
20030125734	Mollenauer	Jul 2003	A1
20030139741	Goble et al.	Jul 2003	A1
20030181910	Dycus	Sep 2003	A1
20030199863	Swanson et al.	Oct 2003	A1
20030199870	Truckai	Oct 2003	A1
20030229344	Dycus et al.	Dec 2003	A1
20030236549	Bonadio et al.	Dec 2003	A1
20040006340	Latterell	Jan 2004	A1
20040010289	Biggs et al.	Jan 2004	A1
20040068274	Hooven	Apr 2004	A1
20040068304	Paton et al.	Apr 2004	A1
20040073247	Loshakove et al.	Apr 2004	A1
20040082946	Malis	Apr 2004	A1
20040092922	Kadziauskas et al.	May 2004	A1
20040122423	Dycus	Jun 2004	A1
20040162557	Tetzlaff et al.	Aug 2004	A1
20040193148	Wham	Sep 2004	A1
20040215127	Kadziauskas et al.	Oct 2004	A1
20040225288	Buysse	Nov 2004	A1
20040250419	Sremich	Dec 2004	A1
20050004563	Racz et al.	Jan 2005	A1
20050004564	Wham et al.	Jan 2005	A1
20050015125	Mioduski et al.	Jan 2005	A1
20050021027	Shields et al.	Jan 2005	A1
20050033282	Hooven	Feb 2005	A1
20050033352	Zepf	Feb 2005	A1
20050080319	Dinkier, II et al.	Apr 2005	A1
20050090815	Francischelli et al.	Apr 2005	A1
20050096681	Desinger et al.	May 2005	A1
20050101951	Wham	May 2005	A1
20050107785	Dycus	May 2005	A1
20050113817	Isaacson	May 2005	A1
20050113819	Wham et al.	May 2005	A1
20050124915	Eggers et al.	Jun 2005	A1
20050124987	Goble	Jun 2005	A1
20050137592	Nguyen et al.	Jun 2005	A1
20050149017	Dycus	Jul 2005	A1
20050159745	Truckai	Jul 2005	A1
20050165444	Hart	Jul 2005	A1
20050192568	Truckai et al.	Sep 2005	A1
20050203504	Wham	Sep 2005	A1
20050234447	Paton et al.	Oct 2005	A1
20050245918	Sliwa, Jr. et al.	Nov 2005	A1
20050245922	Goble	Nov 2005	A1
20060020265	Ryan	Jan 2006	A1
20060041254	Francischelli et al.	Feb 2006	A1
20060052777	Dumbauld	Mar 2006	A1
20060079788	Anderson et al.	Apr 2006	A1
20060079878	Houser	Apr 2006	A1
20060129146	Dycus	Jun 2006	A1
20060161190	Gadberry et al.	Jul 2006	A1
20060167450	Johnson	Jul 2006	A1
20060173453	Gruhl	Aug 2006	A1
20060217697	Lau et al.	Sep 2006	A1
20060217706	Lau et al.	Sep 2006	A1
20060217707	Daniel et al.	Sep 2006	A1
20060224152	Behnke et al.	Oct 2006	A1
20060224158	Odom	Oct 2006	A1
20060247498	Bonadio et al.	Nov 2006	A1
20060271042	Latterell et al.	Nov 2006	A1
20070016185	Tullis et al.	Jan 2007	A1
20070043352	Garrison et al.	Feb 2007	A1
20070043353	Dycus	Feb 2007	A1
20070062017	Dycus et al.	Mar 2007	A1
20070088202	Albrecht et al.	Apr 2007	A1
20070090788	Hansford et al.	Apr 2007	A1
20070093800	Wham et al.	Apr 2007	A1
20070123847	Mihori	May 2007	A1
20070135811	Hooven	Jun 2007	A1
20070142833	Dycus	Jun 2007	A1
20070142834	Dumbauld	Jun 2007	A1
20070156139	Schecter	Jul 2007	A1
20070156140	Baily	Jul 2007	A1
20070167941	Hamel et al.	Jul 2007	A1
20070173811	Couture et al.	Jul 2007	A1
20070173813	Odom	Jul 2007	A1
20070173814	Hixson et al.	Jul 2007	A1
20070179499	Garrison	Aug 2007	A1
20070191827	Lishinsky et al.	Aug 2007	A1
20070191828	Houser et al.	Aug 2007	A1
20070203481	Gregg et al.	Aug 2007	A1
20070213712	Buysse et al.	Sep 2007	A1
20070260242	Dycus et al.	Nov 2007	A1
20070276363	Patton et al.	Nov 2007	A1
20070282195	Masini et al.	Dec 2007	A1
20070282320	Buysse et al.	Dec 2007	A1
20070282332	Witt et al.	Dec 2007	A1
20070287997	Tolmei	Dec 2007	A1
20080009860	Odom	Jan 2008	A1
20080015563	Hoey et al.	Jan 2008	A1
20080015564	Wham et al.	Jan 2008	A1
20080015567	Kimura	Jan 2008	A1
20080030206	Podhajsky et al.	Feb 2008	A1
20080039831	Odom et al.	Feb 2008	A1
20080045947	Johnson et al.	Feb 2008	A1
20080058802	Couture	Mar 2008	A1
20080082098	Tanaka et al.	Apr 2008	A1
20080091189	Carlton	Apr 2008	A1
20080114356	Johnson et al.	May 2008	A1
20080125772	Stone et al.	May 2008	A1
20080132893	D'Amelio et al.	Jun 2008	A1
20080167651	Tetzlaff et al.	Jul 2008	A1
20080172048	Martin	Jul 2008	A1
20080188848	Deutmeyer et al.	Aug 2008	A1
20080208246	Livneh	Aug 2008	A1
20080215050	Bakos	Sep 2008	A1
20080215051	Buysse et al.	Sep 2008	A1
20080221565	Eder et al.	Sep 2008	A1
20080228179	Eder et al.	Sep 2008	A1
20080294222	Schecter	Nov 2008	A1
20080300589	Paul et al.	Dec 2008	A1
20080300590	Horne et al.	Dec 2008	A1
20080300591	Darin et al.	Dec 2008	A1
20090012520	Hixson et al.	Jan 2009	A1
20090024126	Artale	Jan 2009	A1
20090275490	Malackowski	May 2009	A1
20090171352	Sutter	Jul 2009	A1
20090248007	Falkenstein	Oct 2009	A1
20120010614	Couture	Jan 2012	A1
20120059371	Anderson et al.	Mar 2012	A1
20120083785	Roy et al.	Apr 2012	A1
20120136347	Brustad et al.	May 2012	A1
20120197243	Sherman et al.	Aug 2012	A1
20120215220	Manzo et al.	Aug 2012	A1
20130018411	Collings et al.	Jan 2013	A1
20130138101	Kerr	May 2013	A1
20130138102	Twomey et al.	May 2013	A1
20130197874	Heckel	Aug 2013	A1
20130267951	Twomey	Oct 2013	A1
20130274743	Banfalvi	Oct 2013	A1
20130296843	Boudrequx et al.	Nov 2013	A1
20130345696	Behnke, II et al.	Dec 2013	A1
20140005658	Rosenbegr	Jan 2014	A1
20140088583	Singh	Mar 2014	A1
20140214019	Baxter, III et al.	Jul 2014	A1
20160310203	Gaspredes et al.	Oct 2016	A1
20160310204	McHenry et al.	Oct 2016	A1

Foreign Referenced Citations (69)

Number	Date	Country
40 24 636	Feb 1992	DE
40 24 636	Dec 1992	DE
10 2005 044 918	Feb 2007	DE
0 315 338	May 1989	EP
0 538 984	Apr 1993	EP
0 570 675	Nov 1993	EP
0 598 202	May 1994	EP
0 717 967	Jun 1996	EP
0 737 447	Oct 1996	EP
0 878 168	Nov 1998	EP
1 054 637	Nov 2000	EP
1 157 666	Nov 2001	EP
1 500 378	Jan 2005	EP
1 535 581	Jun 2005	EP
1 545 361	Jun 2005	EP
1 557 129	Jul 2005	EP
1 634 539	Mar 2006	EP
1 728 475	Dec 2006	EP
1 810 628	Jul 2007	EP
1 634 539	Feb 2008	EP
1 665 995	Feb 2008	EP
1 946 715	Jul 2008	EP
2 106 762	Jul 2009	EP
2 111 812	Oct 2009	EP
2 156 802	Feb 2010	EP
2 301 462	Mar 2011	EP
2 340 792	Jul 2011	EP
2 436 327	Apr 2012	EP
2 436 330	Apr 2012	EP
2 574 300	Apr 2013	EP
2 712 568	Apr 2014	EP
2 777 578	Sep 2014	EP
3 369 392	Sep 2018	EP
2 157 175	Oct 1985	GB
2 462 453	Aug 2008	GB
60-30946	Feb 1994	JP
83-17935	Dec 1996	JP
11-070123	Mar 1999	JP
11-070124	Mar 1999	JP
11-178833	Jul 1999	JP
2000-254135	Sep 2000	JP
2003-135481	May 2003	JP
2003-164463	Jun 2003	JP
2006-109945	Apr 2006	JP
2006-167403	Jun 2006	JP
2007-144201	Jun 2007	JP
2007-195980	Aug 2007	JP
2007-195985	Aug 2007	JP
2008-043789	Feb 2008	JP
2008-259864	Oct 2008	JP
WO 93015662	Aug 1993	WO
WO 97010764	Mar 1997	WO
WO 99040857	Aug 1999	WO
WO 01012090	Feb 2001	WO
WO 2004030553	Apr 2004	WO
WO 2004032776	Apr 2004	WO
WO 2004032777	Apr 2004	WO
WO 2004082495	Sep 2004	WO
WO 2005004735	Jan 2005	WO
WO 05053785	Jun 2005	WO
WO 2006119245	Nov 2006	WO
WO 2006125558	Nov 2006	WO
WO 2007044849	Apr 2007	WO
WO 2007142601	Dec 2007	WO
WO 2008147773	Dec 2008	WO
WO 2009065140	May 2009	WO
WO 2012110996	Aug 2012	WO
WO-2012110996	Aug 2012	WO
WO 2013030349	Mar 2013	WO

Non-Patent Literature Citations (42)

Entry
International Searching Authority/US, The International Search Report and the Written Opinion for International Application No. PCT/US2019/049768 titled “Electrosurgical Generator Verification System.” dated Dec. 11, 2019, 19 pgs.
European Patent Office, Extended European Search Report for European Patent No. 19198318.8, entitled, “Bipolar Electrosurgical Sealer and Divider,” dated Dec. 17, 2019, 10 pgs.
European Patent Office, Invitation to Pay Additional Fees for International Application No. PCT/US2019/049807, titled “Electrosurgical Generator Control System”, dated Dec. 19, 2019, 16 pgs.
International Searching Authority/US, The International Search Report and the Written Opinion for International Application No. PCT/US2019/049807 titled “Electrosurgical Generator Control System.” dated Feb. 12, 2020, 20 pgs.
International Searching Authority/US, The International Search Report and the Written Opinion for International Application No. PCT/US2019/059909 titled “Electrosurgical System,” dated Apr. 28, 2020, 23 pgs.
“New Products” Journal of Medical Engineering and Technology, vol. 19, No. 5 (Sep./Oct. 1995), pp. 189-190.
International Searching Authority/US, The International Search Report and the Written Opinion for International Application No. PCT/US09/39046 titled “Electrosurgical System”, dated Jul. 27, 2009.
International Preliminary Examining Authority/US, International Preliminary Report on Patentability for International Application No. PCT/US09/39046, titled “Electrosurgical System”, dated Mar. 26, 2010.
European Patent Office, European Search Report for European Application No. EP 10 19 2593 dated Mar. 21, 2011, titled Electrosurgical System.
European Patent Office, European Search Report for European Application No. EP 10 19 2614 dated Apr. 18, 2011, titled Electrosurgical System.
European Patent Office, Extended European Search Report for European Application No. EP 10 19 2580 dated Jul. 21, 2011.
International Preliminary Examining Authority/US, International Preliminary Report on Patentability for International Application No. PCT/US09/39046, titled “Electrosurgical System”, dated Jan. 17, 2012.
European Patent Office, The International Search Report and Written Opinion of the International Searching Authority for International Application No. PCT/US2011/054661, dated Mar. 6, 2012.
International Searching Authority/US, The International Search Report and the Written Opinion for International Application No. PCT/US09/39046 titled “Electrosurgical System”, dated Jun. 2, 2012.
U.S. Appl. No. 12/611,352, filed Nov. 3, 2009, titled Tissue Fusion/Welder Apparatus and Method.
U.S. Appl. No. 12/183,970, filed July 31, 2008, entitled Bipolar Electrosurgical Scissors.
U.S. Appl. No. 12/416,128, filed Mar. 31, 2009, entitled Electrosurgical System.
U.S. Appl. No. 12/416,668, filed Apr. 1, 2009, entitled Electrosurgical System.
U.S. Appl. No. 12/416,695, filed Apr. 1, 2009, entitled Electrosurgical System.
U.S. Appl. No. 12/416,765, filed Apr. 1, 2009, entitled Electrosurgical System.
The International Bureau of WIPO, The International Preliminary Report on Patentability for International Application No. PCT/US2011/054661, entitled Electrosurgical Instruments and Connections Thereto dated Apr. 2, 2013.
European Patent Office, European Search Report for European Application No. EP 13 17 4814.7 dated Sep. 30, 2013, titled Electrosurgical System.
International Searching Authority/US, The International Search Report and the Written Opinion for International Application No. PCT/US2015/031452 titled “Electrosurgical Fusion Device”, dated Dec. 3, 2015.
Bertil Vallfors and Bjorn Bergdahl, Automatically controlled bipolar electrocoagulation—“COA-COMP”, Neurosurg. Rev., 1984, pp. 187-190.
US Patent Application No. PCT/US09/39046 filed Mar. 31, 2009, entitled Electrosurgical System.
European Patent Office, European Search Report for European Patent Application No. 12151288, dated Feb. 10, 2012, 8 pgs.
European Patent Office, Supplementary European Search Report for European Patent Application No. 08755322, dated Apr. 18, 2012, 3 pgs.
European Patent Office, Supplementary European Search Report for European Patent Application No. 08755322, dated Jun. 6, 2012, 2 pgs.
U.S. Appl. No. 12/416,751, filed Apr. 1, 2009, entitled Electrosurgical System, now U.S. Pat. No. 8,579,894 issued Nov. 12, 2013.
European Patent Office, Partial European Search Report for European Patent Application No. 15151398.3, dated Jun. 22, 2015, 9 pgs.
European Patent Office, European Search Report for European Patent Application No. EP 14199708.0, entitled “Electrosurgical System,” dated Jul. 10, 2015, 14 pgs.
International Searching Authority/US, The International Search Report and the Written Opinion for International Application No. PCT/US2015/066473 titled “Bipolar Electrosurgical Sealer and Divider.” dated Mar. 31, 2016, 13 pgs.
International Searching Authority/US, The International Search Report and the Written Opinion for International Application No. PCT/US2015/033546 titled “Electrosurgical Seal and Dissection Systems.” dated Apr. 22, 2016, 31 pgs.
The International Bureau of WIPO, The International Preliminary Report on Patentability for International Application No. PCT/US2015/031452, entitled Electrosurgical System dated Dec. 1, 2016, 21 pgs.
International Preliminary Examining Authority/US, International Preliminary Report on Patentability for International Application No. PCT/US2015/033546, titled “Electrosurgical Laparoscopic Sealer and Dissector,” dated Dec. 15, 2016, 22 pgs.
International Preliminary Examining Authority/US, International Preliminary Report on Patentability for International Application No. PCT/US2015/0066473, titled “Bipolar Electrosurgical Sealer and Divider,” dated Jul. 6, 2017, 10 pgs.
European Patent Office, Extended European Search Report for European Application No. EP 21215386.0, dated May 24, 2022, 6 pgs.
European Patent Office, Extended European Search Report for European Application No. EP 17207793.5, dated Jun. 16, 2018, 9 pgs.
European Patent Office, Extended European Search Report for European Application No. EP 18165110.0, dated Jun. 13, 2018, 6 pgs.
International Preliminary Examining Authority/US, International Preliminary Report on Patentability for International Application No. PCT/US2019/059909, titled “Electro surgical System,” dated May 27, 2021, 15 pgs.
International Preliminary Examining Authority/US, International Preliminary Report on Patentability for International Application No. PCT/US2019/049768, titled “Electrosurgical Generator Verification System,” dated Mar. 18, 2021, 13 pgs.
International Preliminary Examining Authority/US, International Preliminary Report on Patentability for International Application No. PCT/US2019/049807, titled “Electrosurgical Generator Control System,” dated Mar. 18, 2021, 13 pgs.

Related Publications (1)

	Number	Date	Country
	20190105096 A1	Apr 2019	US

Provisional Applications (4)

Number	Date	Country
61994192	May 2014	US
61994215	May 2014	US
61994185	May 2014	US
61994415	May 2014	US

Continuations (2)

	Number	Date	Country
Parent	14848116	Sep 2015	US
Child	16209759		US
Parent	PCT/US2015/031452	May 2015	US
Child	14848116		US

Electrosurgical system

Information

Patent Number

Date Filed

Date Issued

Inventors

Original Assignees

Examiners

Agents

CPC

Field of Search

CPC

International Classifications

Disclaimer

Term Extension

Abstract